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                                                                                                                                   Introduction 
1. INTRODUCTION AND OBJECTIVES 
 
The homeostasis of multicellular organisms is maintained by a very complex communication 
network between cells, tissues, and organs. Classical hormones travel long distances and 
reach their destination via the blood system. Cytokines (including interleukins, interferons and 
chemokines) are synthesized by nearly every cell of an organism and act mostly locally. 
Peptide growth factors can act locally but also over long distances and they are expressed by 
many types of cells in almost every tissue or organ. Many growth factors derive from soluble 
precursors that mature through proteolytic cleavage within the cell. Other growth factors are 
synthesized as membrane-anchored molecules and may exert their biological effects on the 
cell surface by interacting with the extracellular domain of receptor tyrosine kinase (RTKs) 
and thereby mediate stimulation through cell-cell contact, a mechanism termed juxtacrine 
action. Once they are targeted to the cell surface they may also yield soluble growth factors by 
proteolytic cleavage (Massague and Pandiella 1993). Growth factors bind cell surface 
receptors and activate a signal transduction cascade, thereby regulating gene expression, cell 
metabolism, differentiation, proliferation, migration and apoptosis. 
Numerous peptide growth factors have been isolated and characterized, including brain-
derived nerve growth factor (BDNF), colony stimulating factor (CSF), fibroblast growth 
factor (FGF), insulin-like growth factor (IGF), keratinocyte growth factor (KGF), nerve 
growth factor (NGF), platelet-derived growth factor (PDGF), vascular endothelial growth 
factor (VDGF) and epidermal growth factor (EGF). 
 
The epidermal growth factor receptor (EGFR) is one of the most intensively studied RTK. It 
is involved in the regulation of diverse physiological and pathological processes. The EGFR 
is activated by a family of ligands including EGF, transforming growth factor–α (TGFA), 
heparin-binding EGF-like growth factor (HBEGF), amphiregulin (AREG), betacellulin 
(BTC), epiregulin, (EREG) and epigen (EPGN) (Cohen 1962; Derynck et al. 1984; 
Higashiyama et al. 1991; Shoyab et al. 1988; Shing et al. 1993a; Toyoda et al. 1995; Strachan 
et al. 2001). 
 
The EGFR and its ligands play important roles in cancer development, and the EGFR was the 
first growth factor receptor which was proposed as a target for cancer therapy. Two classes of 
EGFR antagonists are currently available: highly selective anti-EGFR monoclonal antibodies 
and small-molecule EGFR tyrosine kinase inhibitors (Ciardiello and Tortora 2008). More than 
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10 EGFR-targeting agents are in advanced clinical development for the treatment of various 
human cancer types (Normanno et al. 2003; Ciardiello and Tortora 2001; Mendelsohn and 
Baselga 2003). Two anti-EGFR monoclonal antibodies (cetuximab, panitumumab) and two 
small-molecule EGFR tyrosine kinase inhibitors (erlotinib, gefitinib) have been approved for 
the treatment of four metastatic epithelial cancer types: non-small-cell lung cancer, squamous-
cell carcinoma of the head and neck, colorectal cancer and pancreatic cancer (Ciardiello and 
Tortora 2008). Thus, further studies of ligand-dependent EGFR activation are necessary for 
better understanding role of this system in physiology and pathology, including 
tumorigenesis. 
 
Betacellulin (BTC), a rather poorly characterized EGFR ligand, was initially isolated from the 
conditioned medium of a mouse pancreatic β-cell carcinoma cell line (Shing et al. 1993). 
Although mice lacking BTC expression show no overt phenotype and appear to reproduce 
normally (Jackson et al. 2003), transgenic mice overexpressing the growth factor show a 
whole array of phenotypical alterations (Schneider et al. 2005). At routine necropsy of 
animals at different ages, alterations of the gastrointestinal organs including reduced pancreas 
weight and increased stomach and small intestine weight were observed. In light of the 
importance of the EGFR system in these organs, the present investigation was carried out to 
systematically study the different effects of BTC in the gastrointestinal tract of transgenic 
mice. 
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2. REVIEW OF THE LITERATURE 
 
 
2.1  The Epidermal Growth Factor Receptor family 
 
As a typical RTK, the EGFR consists of an extracellular domain where ligand binding takes 
place, a short transmembrane domain and a cytoplasmic region containing the catalytic 
protein tyrosine kinase (Schlessinger 2000). Depending on their genetic background, mice 
lacking Egfr expression show peri-implantation or midgestational death or survive up to a few 
weeks after birth. Abnormalities of the skin, lungs, gastrointestinal tract, brain and bones can 
be observed in surviving animals (Threadgill et al. 1995; Sibilia and Wagner 1995; Miettinen 
et al. 1995; Wang et al. 2004). 
 
The EGFR was implicated in cancer in the early 1980s when the avian erythroblastosis tumor 
virus was found to encode an aberrant form of human epidermal growth factor (EGF) receptor 
(EGFR/ERBB1/HER1) (Yarden and Sliwkowski 2001). Since then, the ERBB family has 
grown to comprise four related receptors including ERBB2 (HER2/Neu), ERBB3 (HER3) and 
ERBB4 (HER4). A large number of ligands, the EGF-related peptide growth factors, bind the 
extracellular glycosylated domain of ERBB receptors, leading to the formation of both homo- 
and heterodimers. Dimerization consequently stimulates the intrinsic tyrosine kinase activity 
of the receptors and triggers autophosphorylation of specific tyrosine residues within the 
cytoplasmic tail. These phosphorylated residues serve as docking sites for SH2 or 
phosphotyrosine binding domains to signaling molecules involved in the regulation of 
intracellular signaling cascade (Olayioye et al. 2000).  
ERBB2 was first identified as an oncogene present in the DNA of carcinogen-induced rat 
tumors and is overexpressed in several types of cancers (Tzahar and Yarden 1998). Several 
structural and functional evidences indicate that ERBB2 is devoid of an activating ligand and 
acts only in the context of heterodimers with a second ligand-bound ERBB receptor (Klapper 
et al. 1999). In addition, a genome-wide screen designed to identify ERBB ligands based on 
their intron-exon organization failed to detect any novel molecule potentially able to bind 
ERBB2 (Kochupurakkal et al. 2005). ERBB2 is the most widely expressed ERBB and the 
preferred partner for heterodimerization. In terms of signaling, the most potent heterodimer 
complex is the ERBB2/ERBB3 pair. The reason appears to be that this complex can 
efficiently stimulate both cell proliferation and survival and is able to evade downregulation 
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mechanisms, resulting in prolonged signaling (Citri et al. 2003)  This is fascinating given that 
ERBB3 has a dead kinase domain due to substitutions in critical residues of this domain (Guy 
et al. 1994). Thus, ERBB2 and ERBB3 are active exclusively in the context of heterodimers 
(Citri et al.  2003). Targeted disruption of Erbb2 leads to death at mid-gestation (e10.5) due to 
malformation of trabeculae in the heart (Lee et al. 1995). Erbb3 knockout mice also die 
during gestation (e13.5) due to severe neuropathies and defective cardiac development 
(Riethmacher et al. 1997; Erickson et al. 1997). 
ERBB4, like ERBB1, is able to be activated in the form of homodimers. Although to date 
only a few of the signaling pathways activated after ligand-induced autophosphorylation of 
the ERBB4 kinase domain have been identified, these seem to partially overlap with the 
machinery activated by ERBB1 (Carpenter 2003). Erbb4 knockout mice provide no exception 
and die between 10 and 11 days after fertilization as a consequence of aberrant cardiac and 
neural development (Gassmann et al. 1995). 
 
2.2  Ligands of ERBB receptors 
 
Eleven different peptide growth factors are able to bind the ERBB receptors and they can be 
divided into three groups according to their binding specificity: The first group binds uniquely 
the ERBB1 receptor and its members are EGF, TGFA, EPGN and AREG; the second group 
binds ERBB1 and ERBB4 and includes BTC, EREG and HBEGF; the third group is 
represented by the neuregulins (NRG). NRG-1 (Marchionni et al. 1993) and NRG-2 (Chang 
et al. 1997) bind ERBB3 and ERBB4, while NRG-3 (Zhang et al. 1997) and NRG-4 (Harari 
et al. 1999) are able to bind ERBB4. In addition, Pinkas-Kramarski and co-workers have 
shown that the oncogenic heterodimer ERBB2/ERBB3 can be activated by BTC and EGF 
(Pinkas-Kramarski et al. 1998). 
All EGFR ligands share a characteristic sequence of 36-40 amino acids including six 
conserved cysteine residues in the following pattern: CysX7CysX4-5CysX10-13CysX1CysX8Cys 
(X represents any amino acid). This domain, known as the EGF motif, contains three disulfide 
bonded intramolecular loops (A-loop, Cys1-Cys3; B-loop Cys2-Cys4; C-loop Cys5-Cys6). This 
motif is important for receptor binding and activation of the intrinsic kinase domain. All 
ligands are synthesized as membrane anchored precursors which are shed by 
metalloproteases, members of the ADAM (a disintegrin and metalloproteinase) family, to 
release the mature form. ADAMs are membrane bound glycoproteins with various functions 
including the shedding of membrane anchored proteins but also in fertilization, neurogenesis 
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and angiogenesis (Black and White 1998; Schlondorff and Blobel 1999; Primakoff and Myles 
2000; Seals and Courtneidge 2003). ADAM17 is implicated in shedding TGFA, HBEGF, 
EREG and AREG (Jackson et al. 2003; Merlos-Suarez et al. 2001; Sunnarborg et al. 2002). 
HBEGF can also be cleaved from the cell surface by ADAM9, ADAM10, and ADAM12 
(Izumi et al. 1998; Asakura et al. 2002; Lemjabbar and Basbaum 2002). Furthermore, 
ADAM10 is a major sheddase for BTC and EGF. It is known that the membrane-anchored 
precursors often remain uncleaved at the cell surface and communicate with adjacent cells 
through juxtacrine stimulation (Tada et al. 1999).  
 
 
 
ErbB2
ErbB2
ErbB2
ErbB2
ErbB3
ErbB4
ErbB1
ErbB3
ErbB3
ErbB3
ErbB3
ErbB4
ErbB4
ErbB4
ErbB4
ErbB1
ErbB1
ErbB1
ErbB1
EPGN
AREG
EGF
HBEGF
EREG
BTC
PPP PPPPPPPPP PPPP
TGFA
 
 
Fig. 2.1 Schematic illustration of binding specificities of the EGF-related peptide growth 
factors   
 5
                                                                                                               Review of the Literature 
 
2.3  Betacellulin 
 
BTC, a 32-kDa glycosylated protein, was initially purified from a mouse pancreatic β-cell 
carcinoma cell line (Shing et al. 1993). BTC is expressed in a wide variety of tissues, 
particularly in the pancreatic β-cells, stomach, small intestine, lung, kidney and uterus (Shing 
et al. 1993; Seno et al. 1996; Kojima et al. 2003). BTC was also found in high concentrations 
in the milk, what suggested a function in the mammary gland (Dunbar et al. 1999). 
The mouse Btc gene is mapped to the middle region of chromosome 5. The DNA sequence of 
Btc consist six exons (1-6) and five introns (a-e), but only the first five exons encode the 
protein (Fig. 2.2). Exon 6 encodes the 3’UTR (un-translated-region). The lengths of exons 1-6 
are 400, 99, 118, 147, 108, 242 bp and the lengths of introns a-e are approximately 7.8, 8.9, 
3.8, 1.4 and 1.4 kb. The protein includes 177 amino acids and is synthesized as membrane-
anchored precursor (Fig. 2.2) which can be proteolytically cleaved by members of the ADAM 
family to release the soluble mature form of 80 amino acids (aa32-111) (Dunbar and Goddard 
2000b). The precursor form contains the following domains: a signal peptide (aa13-26), a short 
propeptide (aa27-31), the mature BTC form (aa32-111), a juxtamembrane domain (aa112-124), a 
transmembrane domain (aa125-138) and a cytoplasmic tail (aa139-177). BTC is subject to 
extensive glycosylation and the human membrane-bound precursor form contains an Arg-
Gly-Asp (RGD) sequence, suggesting an active role of this form in mediating cell-cell 
interactions.  
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Fig. 2.2 Schematic illustration of the structure of murine BTC. 
 
Like all ligands of the EGFR, BTC contains an EGF motif, but it is the only member of the 
family having two additional cysteine residues that may form a fourth loop via an additional 
disulfide bridge (Cys15-Cys22). BTC is able to activate ERBB1 and ERBB4 homodimers and 
every possible combination of heterodimers (Fig. 2.1) (Dunbar and Goddard 2000b).   
The protein sequence of BTC has been isolated from several organisms and is shown in Fig. 
2.3. A comparison of amino acid sequence identity in various regions of the BTC indicates 
that the highest degree of sequence similarity is found in the EGF motif, suggesting high 
selection pressure on this region (Fig. 2.2). 
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Recently, Dunbar and colleagues have identified a novel splice isoform of human BTC 
originally termed BTC-β, but now called BTC-δ4 (Dunbar and Goddard 2000a). Because 
exon 4 is skipped, BTC-δ4 lacks the C-loop and the transmembrane domain, which leads to a 
deletion of 147 nucleotides encoding 49 amino acids at positions Cys95-His144. The absence of 
the transmembrane domain suggests that BTC-δ4 may be a secreted protein. BTC-δ4 does not 
bind to any ERBB receptor and shows no evidence of acting like a BTC antagonist. However, 
it was demonstrated that BTC-δ4 acts as an inducer of differentiation of pancreatic β-cells in 
vitro and in vivo, possibly through a novel cell surface receptor (Ogata et al. 2005). 
Different observations indicate that BTC plays an important role in pancreatic islet 
physiology. Btc expression was detected by RT-PCR in isolated pancreatic islets from mice 
(Shing et al. 1993), by Northern blot analysis in human pancreas (Seno et al. 1996) and by 
immunohistochemistry in the endocrine precursor cells of human fetal pancreas and in islet 
non-β-cells and duct cells of adult human pancreas (Miyagawa et al. 1999). BTC is able to 
significantly stimulate the proliferation of diverse pancreatic cancer cell lines (Huotari et al. 
1998; Kawaguchi et al. 2000; Buteau et al. 2003) and human (Demeterco et al. 2000) or rat 
(Sundaresan et al. 1998) fetal pancreatic cells. Addition of BTC to isolated rat islets increased 
not only the proliferation, but also the expression of Pax4, encoding a key transcription factor 
for β-cells (Brun et al. 2004). Furthermore, BTC is able to convert AR42J pancreatic exocrine 
tumor cells (Mashima et al. 1996), PDX-1-transfected glucagon-producing alpha cells 
(Watada et al. 1996), intestinal crypt-like cells (Yoshida et al. 2002) or hepatoma cells (Li et 
al. 2005) into insulin-producing cells. Addition of BTC to the culture medium restored the 
lost β-cell phenotype in human islet-derived cells as demonstrated by induction of expression 
of different β-cell genes, synthesis, storage and glucose-induced release of high levels of 
insulin (Ouziel-Yahalom et al. 2006). Significantly, studies using embryonic pancreatic 
explant cultures demonstrated that betacellulin increased significantly the formation of β-cells 
within the islet, this effect being dependent on the presence of the epidermal growth factor 
receptor (Huotari et al. 2002). 
Several animal studies also confirmed the role of BTC as a β-cell growth factor. 
Transplantation of insulin-producing cells derived from non-endocrine cells treated with BTC 
significantly reduced glucose levels of streptozotocin-treated mice (Ogata et al. 2004). Btc 
expression was shown to be increased from day 3 after partial duct ligation in mice (a model 
for pancreatic regeneration) (Li et al. 2003b). Moreover, injection of recombinant BTC 
promoted β-cell regeneration in 90% pancreatectomized rats (Li et al. 2001) and improved 
glucose tolerance and β-cell volume in diabetic mice (Yamamoto et al. 2000; Li et al. 2003a) 
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and rats (Li et al. 2004). Finally, use of an adenoviral delivery system to express Btc together 
with the transcription factor gene Neurod1 not only resulted in the appearance of cell clusters 
resembling the pancreatic islets in the liver but also normalized glucose levels in diabetic 
mice (Kojima et al. 2003). 
 
Mice lacking Btc expression are viable and fertile and show no overt defects (Jackson et al. 
2003). Transgenic mice overexpressing BTC ubiquitously exhibit a whole range of 
phenotypical alterations including high early postnatal mortality, impaired growth and 
reduced adult body weight, bone alterations, cataract and retinal problems, and pulmonary 
pathology (Schneider et al. 2005).  
 
BTC was identified as one of the EGFR ligands expressed in the mouse uterus exclusively at 
the sites of blastocyst apposition at the time of attachment reaction (day 4) and through the 
early phase of implantation (day 5) (Das et al. 1997). In addition, it was identified as a 
mediator of luteinizing hormone (LH) (Park et al. 2004; Ashkenazi et al. 2005; Hernandez-
Gonzalez et al. 2006), prostaglandin (PG) and progesterone receptor (PGR) (Shimada et al. 
2006) actions in the ovulatory follicle. Finally, BTC was recently identified as a possible 
ovarian mediator of bone morphogenetic protein 15 actions, an oocyte-specific growth factor 
that plays a major role in determining ovulation quota in mammals (Yoshino et al. 2006).  
Investigations of the fertility of BTC transgenic mice showed a delayed implantation, a 
significant reduction of litter size, and a decreased response of the ovaries to gonadotropins. 
Impaired fertilization was found to be the reason for the smaller litter size and this effect 
could be rescued by treatment with exogenous gonadotropins. In vitro maturation and 
fertilization rates of transgenic oocytes were also significantly reduced. The fertilization 
defect was linked with increased MAPK3/MAPK1 activity, the convergence spot of EGFR 
and LHR signaling (Gratao et al. 2007).  
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1 MDPTAPGSSVSSLPLLLVLALGLAILHCVVADGNTTRTPETNGSLCGAPGENCTGTTPRQKVKTHFSRCPKQYKHYCIHGRCRFVVDEQTPSCICEKGYFGARCERVDLFYLQQDRGQILVVCLIVVMVVFIILVIGVCTCCHPLRKHRKKKKEEKMETLDKDKTPISEDIQETNIA           
2 MDRAARCSGASSLPLLLALALGLVILHCVVADGNSTRSPETNGLLCGDPEENCAATTTQSKRKGHFSRCPKQYKHYCIKGRCRFVVAEQTPSCVCDEGYIGARCERVDLFYLRGDRGQILVICLIAVMVVFIILVIGVCTCCHPLRKRRKRKKKEEEMETLGKDITPINEDIEETNIA          
3 MDRAARGSGASSLPLLLALALGLVILHCVVADGNSTRSPETNGLLCGDPEENCAATTTQSKRKGHFSRCPKQYKHYCIKGRCRFVVAEQTPSCVCDEGYIGARCERVDLFYLRGDRGQILVICLIAVMVVFIILVIGVCTCCHPLRKRHKRKKKEEEMETLDKDITPVNEDIEETNIA          
4 MARAAPGSGASPLPLLPALALGLVILHCVLADGNSTRSPEDDGLLCGDHAENCPATTTQPKRRGHFSRCPKQYKHYCIKGRCRFVVAEQTPSCVCDEGYAGARCERVDLFYLRGDRGQILVICLIAVMVIFIILVVSICTCCHPLRKRRKRRKKEEEMETLGKDITPINDDIQETSIA          
5 MDRAAPGSGASSLPLLLALALGLVILQCVVADGNSTRSPETNGLLCGDPDENCAATTTQSKRKGHFSRCPKQYKHYCIKGRCRFVVTEQTPSCVCDEGYIGARCERVDLFYLKGDRGQILVICLIAVMVVFIILVIGVCTCC                                               
6             VPLLSAFVMSLVILQCVVADGNTTRTPETNGSLCGAPGENCTGTTPRQKSKTHFSRCPKQYKHYCIHGRCRFVMDEQTPSCICEKGYFGARCEQVDLFYLQQDRGQILVVCLIGVMVLFIILVIGVCTCCHPLRKHRKKKKEEKMETLSKDKTPISEDIQETNIA                    
7                    GLAILHCIVADGNSTRGPEKDGLLCGDPGGNCAGAATTARWRRRGHFGRCPQRYEHYCLKGRCRFVVAEQTPSCVCDEGYTGARCERVDLFYLRGDRGQILVICLIAVMVIFIILVVGVCTCCHPLRRRRKRRKKEEEMETLGKDITPINEDIQETSIA  
 
 
                         Fig. 2.3  Amino acid alignment of the BTC-sequence  from Mus musculus (1), Homo sapiens (2), Pan troglodytes (3), Bos taurus (4),  
                         Macaca mulatta (5), Rattus norvegicus (6) and Canis familiaris (7). Conserved cysteine residues are indicated by blue color  
                         Colors in the mouse sequence marker the signal peptide (green), short propeptide (dark blue), mature BTC form (yellow),  
                         juxtamembrane domain (turquoise), a transmembrane domain (red), cytoplasmatic tail (grey). 
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2.4 Gastrointestinal tract 
 
2.4.1 Stomach 
 
The stomach is an enlarged part of the digestive tube specialized for enzymatic and hydrolytic 
breakdown of food into digestible nutrients. In the mouse, it is located in the left cranial part 
of the abdominal cavity, partially covered by the left lateral hepatic lobe. Its left half is 
formed by the forestomach (pars cardiaca, saccus cecus), the right half by the glandular 
stomach (pars fundica et pars pylorica). The gastric wall consists of all the layers of a typical 
tubular organ. The mucosa is composed by epithelium, lamina propria and lamina muscularis, 
followed by the submucosa. The tunica muscularis has three layers, an inner oblique, a middle 
circular and an outer longitudinal layer. A serosa covers the gastric wall to the outside.  
The nonglandular region has a distinct lamina muscularis and is separated through the margo 
plicatus (limiting ridge) from the glandular part of the stomach. 
The glandular region present a single columnar epithelium, and the surface is studded with 
invaginations called gastric pits (foveolae gastricae) which are continuous with the gastric 
glands and receive their secretory products. The surface epithelial cells have a rapid turnover; 
lining cells from the gastric pits replace the epithelium every three to four days. 
The cardiac gland region contains mucous cardiac glands. The fundic gland region contains 
three types of glands: mucous neck cells, granular eosinophilic parietal cells producing 
hydrochloric acid and basophilic chief cells producing zymogene. The pyloric gland region 
contains mucous pyloric glands. (Berdanier 2004; Dellmann and Brown 1987; Welsch 2003) 
The EGFR is expressed in the normal stomach and TGFA is predominantly present in the 
parietal cells and in the epithelial cells of the gastric body and fundus. Increased expression of 
TGFA could be detected in patients with Ménétrier disease (Dempsey et al. 1992). Ménétrier 
disease is a rare gastric hyperproliferative disorder of uncertain etiology which was first 
described 1888 by Pierre Ménétrier (Ménétrier 1888). Patients present a unique constellation 
of signs and symptoms that include abdominal pain, nausea, vomiting, hypochlorhydria, 
hypoalbuminemia and edema of peripheral tissues. Clinically it occurs more commonly in 
middle-aged males than females (Morson and Dawson's 1990). The central histological 
feature is hypertrophy of the gastric mucosa with giant rugal folds, atrophy of the body 
glandular compartment, marked expansion of surface mucous cells (foveolar hyperplasia) and 
cystic dilation of the gastric glands (Scott, Jr. et al. 1975; Searcy and Malagelada 1984; 
Larsen et al. 1987; Sundt, III et al. 1988; Wolfsen et al. 1993). Two major lines of evidence 
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strongly indicate that hyperactivation of the EGFR by local overproduction of its ligand 
TGFA contributes to Ménétrier disease. First, increased expression of TGFA could be 
detected in patients with Ménétrier disease (Dempsey et al. 1992), and structural and 
functional lesions of the stomach (including foveolar hyperplasia and glandular cystic 
dilation, decreased acid production, reduced number of parietal cells, and increased neutral 
mucin production) were described in transgenic mice overexpressing TGFA (Dempsey et al. 
1992; Takagi et al. 1992) in this organ. Second, a functional proof of this concept results from 
the observation that patients suffering from Ménétrier disease are being successfully treated 
with the monoclonal antibody Cetuximab directed against the EGFR (Burdick et al. 2000; 
Coffey et al. 2007). 
Before it was known that enhanced EGFR signaling is caused by TGFA overexpression in 
Ménétrier disease, the therapy involved anticholinergic agents, octreotide, acid suppression, 
prednisone and Helicobacter pylori eradication, but results used to be inconsistent. The fact 
that TGFA is overexpressed in Ménétrier disease motivated the treatment of Ménétrier disease 
patients with the monoclonal antibody Cetuximab directed against the EGFR (Coffey et al. 
2007).  
 
2.4.2 Small intestine 
 
The small intestine is formed by the duodenum, jejunum and ileum. It has a nutrient 
absorptive function and is supported by the pancreas, liver and bile. Circularly disposed 
mucosal folds, fingerlike projections (intestinal villi) and microvilli of the surface of the 
epithelial cells of the villi increase the surface of the small intestinal enormous and enhance 
so the absorptive function. 
The tunica mucosa includes epithelium, lamina propria and lamina muscularis. The most 
characteristic features of the small intestine are the mucosal villi. The intestinal glands 
(crypts), which open into pits between the bases of the villi, penetrate the mucosa as far as the 
lamina muscularis. 
The columnar absorbing cells have prominent microvilli, and they are interspersed by 
numerous goblet cells. The apical portion of the goblet cells is filled up with mucin which is 
secreted into the lumen of the small intestine. Junctional complexes are located between the 
epithelial cells to prevent the fluid of the intestinal contents from diffusing into the lamina 
propria. Granular cells of Paneth are located near the base of the intestinal crypts. They 
produce lysozymes and peptidases. The lamina propria is a loose connective tissue that forms 
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the core of the villi and surrounds the intestinal glands. It encloses blood and lymph vessels, 
leukocytes, fibrocytes, smooth muscle cells, plasma cells and mast cells.  
The lamina muscularis of the small intestine is composed of inner circular and outer 
longitudinal layers of smooth muscles. Diffuse lymphatic tissue or solitary lymphatic nodules 
are scattered throughout the lamina propria. 
The tela submucosa is a layer of collagen and elastic fibers containing tubuloalveolar 
submucosal glands. The secretory products lubricate the surface epithelium and protect it 
from the acid gastric chyme. Solitary nodules are present in the submucosa of the whole small 
intestine.  
The tunica muscularis consists of an inner circular and an outer longitudinal smooth muscle 
layer. 
The tunica serosa is loosely connected with the mesentery (Berdanier 2004; Dellmann and 
Brown 1987; Welsch 2003).  
Egfr knockout mice show a disorganization of the intestinal crypt architecture (Threadgill et 
al. 1995) and hemorrhagic enteritis (Miettinen et al. 1995). Mutations in the EGFR ligands 
have resulted in much milder phenotypes. For example, triple knockout mice lacking EGF, 
TGFA and AREG show only minor defects in gastrointestinal development (Troyer et al. 
2001), and mice lacking Tgfa (Egger et al. 1997) or Ereg expression (Lee et al. 2004) show 
increased susceptibility to intestinal damage caused by oral administration of dextran sulfate 
sodium. The effects elicited by overexpressing EGFR ligands in the intestinal epithelium are 
also relatively mild: EGF transgenic mice show enhanced intestinal adaptation after small 
bowel resection (Erwin et al. 1999), while TGFA overproduction resulted in increased crypt 
cell proliferation (Acra et al. 1998) and protected transgenic mice from DSS-induced colitis 
(Egger et al. 1998). 
The levels of EGFR or its ligands are often increased in tumors as compared to the unaffected 
surrounding tissue (Messa et al. 1998); in fact, deregulation of EGFR signaling is frequently 
associated with tumorigenesis (Normanno et al. 2006; Zandi et al. 2007). It has been 
previously demonstrated that the hypomorphic allele Egfrwa2 (Roberts et al. 2002) and the 
antimorphic allele Egfrwa5 reduce the multiplicity of adenomas in the Apc+/Min mouse model of 
familial adenomatous polyposis.  
Infusion of BTC into rats resulted in a moderate increase in intestinal growth, with maximal 
effects on ileum and proximal colon crypt hyperplasia (Howarth et al. 2003).  
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2.4.3 Large intestine 
 
The large intestine is composed of the caecum, colon and rectum. It is the site for microbial 
action on the ingesta, absorption of water, vitamins and electrolytes. Characteristics common 
to all segments of the large intestine are the absence of villi, large number of goblet cells and 
the increased number of lymphatic nodules. Plicae circulares are absent in the large intestine 
but longitudinal folds are present.  
The colon has a big size in the mouse and is an important bacterial fermentation reservoir and 
has a substantial number of lymphatic nodules scattered throughout its length. 
The tunica mucosa of the colon is thicker and the length of the intestinal glands is increased 
compared to the small intestine. 
The basic structures of the rectum are similar to the colon, but the numbers of goblet cells are 
increased compared to the colon (Berdanier 2004; Dellmann and Brown 1987; Welsch 2003).  
 
2.4.4 Exocrine pancreas 
 
The pancreas is located in the mesentery of the duodenal loop and the transverse colon and in 
the greater omentum close to the stomach and spleen. It contains both exocrine and endocrine 
units. The islets of Langerhans represent the endocrine pancreas and they synthesize the 
hormones insulin (β-cells), glucagon (α-cells), somatostatin (δ-cells) and pancreatic 
polypeptide (PP-cells). 
The exocrine pancreas is an acinar gland. The secretory acinar cells are of pyramidal shape 
and have large nuclei surrounded by a well developed endoplasmatic reticulum. The acini are 
connected to intercalated ducts leading to intralobular and then to interlobular ducts which 
open to the main excretory ducts leading to the duodenal papilla. They produce amyloitic 
(amylase), lipolytic (lipase, phospholipase a, cholesterinesterase), nuclei acid splitting 
(ribonuclease, desoxyribonuclease) and proteolytic (trypsin, chymotrypsin, carboxypeptidase, 
aminopeptidase, elastase) enzymes. All these enzymes have a function in digestion and their 
pH optimum is in the alkaline region. The proteolytic enzymes are coupled with an inhibitor 
to protect the pancreas from autodigestion, so called zymogenes (Berdanier 2004; Dellmann 
and Brown 1987; Welsch 2003).  
It is known that EGF acts directly on acinar cells and stimulates pancreas growth (Dembinski 
et al. 1982) and modulates pancreatic secretion (Konturek et al. 1984). Overexpression of the 
ERBBs and multiple EGFR ligands is observed in pancreatic ductal adenocarcinoma and in 
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chronic pancreatitis (Zhu et al. 2000). In addition, transgenic mice overexpressing TGFA 
(Sandgren et al. 1990; Jhappan et al. 1990; Bockman and Merlino 1992; Wagner et al. 1998; 
Wagner et al. 2001) or HBEGF (Means et al. 2003) exhibit pancreatic fibrosis and ductal 
metaplastic lesions. Rats with caerulein-induced pancreatitis were treated with EGF and 
showed decreased amylase and lipase levels (Warzecha et al. 1999), suggesting that this 
EGFR ligand has a protective effect against acute pancreatitis. 
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3. Animals, Material and Methods 
 
3.1 Animals 
 
All animals were maintained under specific pathogen free conditions in the facilities of the 
Gene Center at 22°C, 65% humidity, and with a 12 h light cycle and received standard food 
(V1124; Ssniff, Soest, Germany) and water ad libitum. Mice used in expression studies and 
for phenotype analysis were weaned at an age of three weeks, marked by ear piercing and 
housed in Makrolon cages type 2 or 3 separated by sex. At the time of weaning, tail tips were 
clipped, frozen on dry ice, and stored at -80°C for genotype analysis.  
All animal experiments were carried out in accordance with the German Animal Protection 
Law with permission from the responsible veterinary authority (AZ 55.2-1-54-2531-19-03 
and AZ 209.1/211-2531-10/04). 
 
3.1.1 BTC transgenic mice 
 
The betacellulin-coding sequence was amplified from mouse lung cDNA by PCR (BD 
Advantage cDNA PCR, Clontech) using the primers BTC#1 (5’-GGC CCA GGA AGG GCA 
TAG AGA-3’) and BTC#2 (5’-ATG AGT CAG GTC TTT TGT AGC TTG-3’). The product 
was inserted into the pCR II-TOPO cloning vector (Invitrogen), released as an EcoRI 
fragment and cloned downstream of the cytomegalovirus enhancer, chicken β-actin promoter 
and rabbit β-globin splice acceptor, and upstream to the rabbit β-globin 3’-flanking region 
and polyadenylation signal in the expression vector pUC-CAGGS (a courtesy of Dr. Jürgen 
Bachl, GSF, Munich). Orientation and amplification fidelity were checked by sequencing 
using the primer pTORUseq: 5’-CTA CAG CTC CTG GGC AAC GTG-3’. The relevant 
sequence was released from the vector backbone by SalI/HindIII (MBI, St. Leon-Rot, 
Germany) double digestion.  
Three different BTC-overexpressing lines (L2, L4, and L5) were established by pronuclear 
DNA microinjection into fertilized oocytes (zygotes) from the inbred strain FVB/N (Taketo et 
al. 1990). Zygotes were transferred into the oviducts of pseudopregnant synchronized 
recipient mice from the outbred stock NMRI. FVB/N and NMRI mice were obtained from 
Janvier, Le Genest Saint Isle, France. In L5, the transgene appeared to be X-linked since its 
transmission through males was restricted to female offspring (data not shown). Thus, to 
avoid complications related to the transmission pattern and expression levels (due to 
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functional mosaicism in transgenic females), animals from L2 and L4 were used for further 
studies. We observed similar alterations in these two independent transgenic lines carrying the 
transgene at different integration sites, indicating that the effects described below are indeed 
the consequence of increased BTC expression and not caused by random integration events. 
 
3.1.2 EgfrWa5 mice 
 
EgfrWa5 mice were generated during a large-scale N-ethyl-N-nitrosourea (ENU) mutagenesis 
program and carry a mutation altering the highly conserved DFG motif within the activation 
loop of the EGFR kinase domain (Lee et al. 2004). As a consequence, this allele encodes a 
kinase dead receptor. Heterozygous EgfrWa5 mice have opened eyes at birth, a wavy coat and 
an abnormal placental architecture, while homozygous embryos die during gestation. EgfrWa5 
mice were donated by the Medical Research Council (Oxfordshire, UK) via Dr. David 
Threadgill (University of North Carolina, NC, USA). They were maintained in a C57BL/6N 
background. Genotyping was determined by PCR using a primer combination mEgfr-Ex21-S5 
(5’-GCATGTCAAGATCACAGA-3’) and mEgfr-In21-As1 (5’-TAGAGAATGACCCTG 
ACGAG-3’) for the wild-type allele Egfr and mEgfr-Ex21-S6 (5’-GCATGTCAAGAT 
CACAGG-3’) and mEgfr-In21-As1 for the EgfrWa5 allele. Both primer pairs amplify a product 
of 228 bp.  
 
3.1.3 Apc+/Min mice 
 
C57BL/6J- Apc+/Min mice were purchased from the Jackson Laboratory (Bar Harbor, USA). 
This mouse line is also derived from an ENU mutagenesis program and carries a mutation in 
the tumor suppressor gene Apc. Since the animals develop multiple adenomas throughout the 
intestinal tract, the mutant gene was named multiple intestinal neoplasia (Min). Like familial 
adenomatous polyposis (FAP), a disease with a mutation in the APC gene, localized on 
chromosome 5q21 of the patients, the Min gene mutation causes an autosomal dominant trait. 
Homozygous mutation of the Apc gene leads to embryonic lethality so that studies were 
conducted in heterozygous Apc+/Min mice. The average life span of Apc+/Min animals is 119 
days. 
Mice were genotyped for Mom1 status, a modifier allele known to influence adenoma 
multiplicity, by PCR amplifying a 500 bp region (primers: 5’-GTCCAAGGGAACATTGCG-
3’ and 5’-AGAACAGGTGATTTGGCCC-3’) and digested with BamHI (MBI, St. Leon-Rot, 
 17
                                                                                                    Animals, Material and Methods 
Germany). Finally, the digest was separated on a 1.5 % agarose gel to detect the Mom1 allele 
status. 
 
 
Digest:     PCR-product        20 µl 
                BamHI buffer         5 µl 
                BamHI                    1 µl 
                Bidistilled water   24 µl 
The digest was incubated for 1 h at 37°C. 
 
3.2 Human stomach samples 
 
Human stomach biopsy samples from Ménétrier and PGA patients were kindly provided by 
PD Dr. M. Vieth and Prof. Dr. M. Stollte from the Institute of Pathology, Klinikum Bayreuth, 
Germany. Informed consent was obtained from the patients.  
 
3.3 Principle of the Polymerase Chain Reaction (PCR) 
 
PCR is an in vitro method that allows up to a billion-fold amplification of a selected DNA 
sequence. The reaction uses two oligonucleotide primers that hybridize two opposite strands 
and flank the target DNA sequence that is to be amplified. In the presence of 
deoxyribonucleoside triphosphates (dNTPs), a heat-stable DNA polymerase catalyzes the 
elongation of the primers. A repetitive series of cycles involving template denaturation, 
primer annealing, and extension of annealed primers by the polymerase results in exponential 
accumulation of the specific DNA fragment. Because the primer extension product 
synthesized in a given cycle can serve as a template in the next cycle, the number of target 
DNA copies increases exponentially corresponding to each cycle. 
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3.3.1 PCR protocol for detecting the Btc transgenic sequence 
 
Taq DNA polymerase Kit (Qiagen) containing: 
PCR Buffer, 10x Tris-HCl, KCl, (NH4)2SO4, 15 mM MgCl2, pH 8.7 (20°C) 
Q-Solution 5x concentrated 
MgCl2 25 mM 
Taq Polymerase 5 U/µl, recombinant 94-kDa DNA polymerase, isolated from 
Thermus aquaticus, cloned in E. coli 
dNTPs Set 100 mM aqueous solutions of dATP, dCTP, dGTP and dTTP, 
each in a separated vial 
 
Ethidium bromide 0,1% solution in bidistilled H2O 
50x TAE running buffer 242 g Tris 
 57.1 ml Glacial Acetic Acid 
 100 ml EDTA, 0.5 M, ph 8.0 
 Ad 1 l bidistilled H2O 
6x Loading Dye 30% glycerol 
 bromophenol blue 
 
To confirm the integrity of the DNA, a sequence of the β-actin gene was amplified using the 
following primers: 
β-actin sense 5’-GGC ATC GTC ATG GAC TCC -3’ 
β-actin  antisense 5’-GTC GGA AGG TGG ACA GGG -3’ 
 
For detection of the construct integration, following primers were used: 
pTORUseq  5’-CTA CAG CTC CTG GGC AAC GTG-3’ 
globpA  5’- AGA TCT CAG TGG TAT TTG TGA GCC 3’ 
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3.3.2 Assay procedure 
 
The 20 µl reaction was prepared in 100-µl PCR tubes on ice, containing:  
DNA template (about 50 ng/µl) 2 μl 
Sense primer (2 µM) 1 μl 
Antisense primer (2 µM) 1 μl 
dNTPs Mix (1 mM) 2 μl 
PCR Buffer, 10x 2 μl 
Q-Solution 4 μl 
MgCl2 (25Mm) 1.25 μl 
Taq Polymerase, 5U/µl 0.1 μl 
Bidistilled H2O 6.65 μl 
  
The amplification took place in a Biometra Uno Thermocycler and was performed as follows: 
  
1st step: Denaturation 94°C for 4 min 
2nd step: Denaturation 94°C for 1 min 
3rd step: Annealing 60°C for 1 min 
4th step: Extension 72°C for 2 min 
5th step: Extension 72°C for 10 min 
6th step: Cooling 4°C 
 
Steps 2 to 4 were repeated 35 times before progression to steps 5 and 6 (36 cycles). PCR 
products were mixed with 6x loading buffer, separated in 2% agarose TAE gels with ethidium 
bromide and visualized under UV light. 
 
 
3.4 Identification of transgenic mice by Southern blot 
 
3.4.1 Extraction of DNA and estimation of concentration 
 
Tail tips were incubated for 10-20 h at 56°C in 1.5 ml centrifuge tubes (Eppendorf, Hamburg, 
Germany) containing 620 µl digestion buffer by gently shaking.  
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Digestion buffer:     0.5 M EDTA pH 8.0  120 µl 
                     proteinase K (20 mg/ml in bidistilled water) 17.5 µl 
                                 Nuclei Lysis Solution (Promega®)  500 µl 
 
After digestion, 3 μl of RNase solution was added to the cooled samples. The samples were 
mixed by inverting them 25 times and incubated for 20 min at 37°C. After cooling down to 
room temperature, 200 μl of Protein Precipitation Solution (Promega®) was added to each 
sample. The samples were vortexed at high speed for 20 seconds, chilled on ice for 5 minutes 
and then centrifuged at 13,000 g x for 4 min. The supernatant was transferred into a clean tube 
containing 600 µl 100 % isopropanol. The DNA became visible as a small white pellet by 
gentle shaking and was centrifuged at 13,000 x g for 2 min. After removing the supernatant, 
600 µl of 70% ethanol were added to wash the DNA and the tubes were inverted several 
times. A last centrifugation step was carried out under the same conditions as above, the 
ethanol was removed and the pellet was air-dried for 10 min. 50 µl of Rehydration Solution 
was added and the DNA were rehydrated by incubating at 65°C for one hour. DNA samples 
were stored at 4°C. DNA concentration was estimated by measuring the optical density (OD) 
of 100 µl of a 1:100 dilution of the samples at 260 and 280 nm in a spectrophotometer 
(Beckman, Palo Alto, USA). Ratios (260/280 nm) between 1.6 and 2.0 were considered to be 
appropriately pure and the DNA concentration was calculated according to the following 
equation:  
DNA concentration (µg/µl): dilution factor x OD260 x 50 (unit factor) 
 
3.4.2 Digestion and transfer of the DNA 
 
10 µg of genomic DNA was digested for 12 h in a centrifuge tube at 37°C: 
 
DNA                                        x µl      
10x buffer TangoTM               10 µl 
NcoI (10U/µl)                         10µl 
bidistilled water up to           100µl 
 
20µl of 6x loading buffer were added and the cleaved DNA was separated in a 0.8% agarose 
TAE buffer with a kb DNA marker for 2-3 h (100V), using 1x TAE as running buffer. 
 
50x TAE:    Tris                                242 g 
                    0.5 M EDTA (pH 8.0) 100 ml  
                    glacial acetic acid       57.1 ml 
                    bidistilled water up to          1l 
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The gel was photographed together with a ruler and shaken for 15 min in 0.25 M HCl. After 
washing two times in distilled water, the gel was shaken for another 30 min in 0.4 M NaOH. 
The DNA was transferred to a nylon membrane by alkaline blotting. The gel was placed 
upside down over a plastic film and air bubbles were removed manually. The gel was then 
overlaid with the nylon membrane, two gel blotting papers and with a stack of paper towels. 
Membrane and papers were cut to fit the gel size and the membrane was cut on the top left 
corner to identify the orientation of the blot. At each step, air bubbles were removed with the 
help of a glass pipette. Finally, a glass dish of approximately 1 kg was positioned at the top 
and capillary transfer took place for 24 hours. Thereafter the membrane was removed and 
nuclei acids were crosslinked by exposition to UV light (120 J/cm²).  
 
3.4.3 Radioactive probe labeling 
 
For both Southern and Northern blots 100 ng of cDNA were labeled with random hexamer 
labeling kit (Rediprime II Random Prime Labelling system, GE Healthcare) using α32P-ATP 
(GE Healthcare) according to the manufacturer’s instructions. 
 
3.4.4 Hybridization, washing and signal detection 
 
The crosslinked membrane was placed into a glass tube and prehybridized with 12 ml Rapid-
Hyb buffer (GE Healthcare) at 65°C for at least 30 min in a hybridization oven. During this 
time, sufficient probe to give a concentration of 2 x 106 cpm/ml in the 12 ml hybridization 
volume was incubated at 95°C for 5 min and than chilled immediately on ice. The denatured 
probe was added directly to the prehybridization solution and hybridization occured, for 2 h at 
65°C. As a standard procedure, three wash steps were performed to remove unspecific 
radioactivity: 
 
1x 20 min at RT with 2xSSC/0.1%SDS 
2x 15 min at 65°C with 1xSSC/0.1%SDS 
 
20xSSC (pH 7.0):    3 M NaCl 
                                 0.3 M sodium citrate 
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The first two washes were put in the radioactive waste, thereafter discarded into the normal 
waste. The membrane was sealed with a plastic film and exposed either to a Storage Phosphor 
Screen (Molecular Dynamics) or to an X-ray film (GE Healthcare). The membrane was not 
allowed to dry any time. If background was still too high, the membrane was washed again 
more stringently (0.5x SSC or even 0.25x SSC/0.1% SDS) and at higher temperatures (up to 
72°C). 
 
 
3.5 Evaluation of gene expression at the RNA level 
 
3.5.1 Extraction of RNA from tissue 
 
Tissue samples stored at -80°C were added directly to a 5-ml plastic tube containing 1 ml of 
the TriPure Isolation Reagent (Roche, Mannheim, Germany) and homogenized in a 
homogenizer (ART Labortechnik) at position D (23500 rpm) for 30 s. Between two samples, 
the homogenizer was cleaned with bidistilled water and 0.2 M NaOH.    
Total RNA was extracted from pancreas tissue by using the RAeasy Kit 50 (Qiagen), 
according to the manufacturer’s manual and dissolved in 100 µl DEPC water. The quality of 
the RNA samples was determined by electrophoresis through 1 % agarose gels and staining 
with ethidium bromide, and the 18S and 28S RNA bands were visualized under ultraviolet 
light. RNA concentration was measured by nano-drop performed according to the 
manufacturer’s instructions.  
 
3.5.2 cDNA synthesis 
 
RNA was reverse transcribed in a final volume of 21 µl. Random Hexamer Primers were 
diluted 1/16. (150 µl bidistilled water + 10 µl Random Hexamer Primers) 
 
Master Mix (1):      Random Hexamer Primers   3 µl 
                               10 mM dNTP Mix                1 µl 
                               5 µg RNA                           10 µl 
 
The master mix was heated for 5 min at 65°C and than chilled on ice. To this mix the master 
mix 2 was added and the mixes were gently merged and heated for 2 min at 25°C. 
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Master Mix (2):      5x First Strand Buffer   4 µl 
                               0.1 mM DTT                 2 µl 
                               RNase out                      1 µl 
 
Finally, 1 µl reverse transcriptase was added to the reaction and the samples were incubated at 
25°C for 10 min and at 42°C for 50 min, then the reverse transcriptase was  inactivated by 
heating at 70°C for 15 min and after that cooled at 4°C for 5 min.  
The cDNA was stored at -20°C.  
 
3.5.3 Northern blot 
 
3.5.3.1 Formaldehyde gel electrophoresis 
 
Gel casting trays and combs were washed thoroughly with 1% SDS and sequentially rinsed 
with hot tap water and bidistilled water. The gel was prepared in a 250 ml Erlenmeyer flask. 
The gel was poured into the chamber and allowed to polymerize for at least 1 h in a fume 
cupboard. 
 
 
 
formaldehyde gel:   agarose                            1.5 g 
                                bidistilled water            111 ml 
                                10x MOPS                      15 ml 
                                37% formaldehyde      24.3 ml 
                                1% ethidium bromide       8 µl 
 
Agarose was dissolved in water and boiled until the solution became clear before adding the 
other components.  
 
10x MOPS:    MOPS                         41.85 g 
                       sodium acetate              6.80 g 
                       bidistilled water up to   800 ml 
 
MOPS and sodium acetate were dissolved in water first and than was 20 ml of a DEPC treated 
0.5 M EDTA solution added and the pH was adjusted with 10 M NaOH or glacial acetic acid 
to 7.0. The volume was adjusted to 1 litre with bidistilled water, sterilized by filtration and 
stored at 4°C. 
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10 µg of total RNA were pipetted into 1.5 ml centrifuge tubes and mixed with the 1.7x RNA 
loading buffer. Samples were incubated at 70°C for 20 min, chilled on ice, mixed with 2 µl 
LB dye (MBI, St. Leon-Rot, Germany) and loaded into the slots. Electrophoresis was 
performed at 100V for 2-3 h in 1x MOPS as the running buffer. 
 
 
1.7x RNA loading buffer:    37% formaldehyde   211 µl 
                                             formamide                633 µl 
                                             10x MOPS                156 µl 
 
 
3.5.3.2 Transfer of the RNA 
 
After the run, the gel was photographed together with a fluorescent ruler to identify the 
position of the 18S and 28S ribosomal RNA. The gel was rinsed briefly with distilled water in 
a plastic box and shaken for 40 min at RT in Solution I (75 mM NaOH/100 mM NaCl) to 
partially cleave the RNA and facilitate the transfer and then for 40 min at RT in Solution II 
(100 mM Tris, pH 7.5) for neutralization. 
 
The transfer was performed on a glass plate which was positioned over a support in a plastic 
box containing transfer buffer (25 mM Na2HPO4, 25 mM NaH2PO4, pH 6.5). A blotting paper 
cut to cover the glass plate was pre-wet in transfer buffer and fixed at its both ends under the 
support to keep contact with the transfer buffer. Air bubbles between paper and glass were 
removed thoroughly with the help of a plastic pipette. Two wet blotting papers slightly larger 
then the gel were placed over the bridge and air bubbles removed with the pipette. The gel 
was placed upside down in the center of the blotting papers and air bubbles were removed 
manually. The nylon membrane, which has been pre-wet for 10 min in transfer buffer, was 
positioned over the gel and overlaid with a wet, same sized blotting paper. This was repeated 
with two other dry blotting papers. Thin strips of parafilm were placed around the gel to avoid 
shortcuts during the transfer. The blotting papers were overlaid with a stack of papers towels 
and a glass dish was placed on the top of the towels. The transfer occurred overnight. On the 
next day wet towels were replaced with fresh ones and buffer was filled up. When the transfer 
was complete the membrane was removed unambiguously marked with a pen and nucleic 
acids were crosslinked by exposition to UV light (120 J/cm²). 
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3.5.3.3 Hybridization, washing and signal detection 
 
Labelling of the probe, hybridization and detection were performed as described for Southern 
blot (3.2.3). The GAPDH probe was excised from the pBluescript II kb(-)/mGAPDH plasmid 
with HindIII. The betacellulin probe was amplified by PCR using the primers indicated 
bellow and cloned into the pCR®II-TOPO vector (Invitrogen) according to the manufacturer’s 
instruction. The probe was excised from a miniprep with EcoRI (MBI). 
 
BTC#1 (sense):         5’-GGC CCA GGA AGG GCA TAG AGA-3’ 
BTC#2 (antisense):   5’-ATG AGT CAG GTC TTT TGT AGC TTG-3’ 
 
3.5.3.4 Striping of membranes 
 
Membranes were stripped by incubating them for 5 min in boiling 0.1% SDS solution and 
then with fresh 0.1% SDS until the solution reached room temperature. Membranes were 
directly reused for pre-hybridization.  
 
3.5.4 Reverse Transcription PCR (RT-PCR) 
 
A DNase I (Roche) digest was performed with 10 µg of total RNA. The reaction mix was 
incubated at 37°C for 30 min. Thereafter the enzyme was inactivated by incubation at 75°C 
for 10 min. 
 
DNase I digest:     RNA                             x µl 
                              10x reaction buffer       2 µl 
                              DNase I                         1 µl 
                              bidistilled water up to 20 µl 
 
5 µl of the DNase reaction were used for reverse transcription with the M-MuLV Reverse 
Transcriptase (MBI), random hexamer primers and DTT  for 60 min at 37°C. Enzyme activity 
was inactivated by incubation at 95°C for 10 min. 2 µl were used in a PCR reaction as 
described previously.  
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DNase digested RNA               5 µl 
random hexamer primers         1 µl 
dNTPs (10 mM)                       2 µl 
5x reaction buffer                     4 µl 
DTT (0.1 mM)                          2 µl 
reverse transcriptase              0.1 µl 
bidistilled water                     5.9 µl 
 
Following primers were used for amplifying the betacellulin gene: 
BTC#1 (sense):         5’-GGC CCA GGA AGG GCA TAG AGA-3’ 
glob-pA (antisense):  5’-AGA TCT CAG TGG TAT TTG TGA GCC-3’ 
 
3.5.5 Quantitative Real –time PCR (TaqMan®, Perkin Elmer 7700) 
 
Quantitative values are obtained from the Ct number at which the increase in the signal 
associated with the exponential growth of PCR products begins to be detected. One 
endogenous RNA control gene (β-actin) was chosen. Cytokine messenger RNA copy 
numbers were normalized to β-actin copies for mouse tissues. Analyzing plasmid dilution 
series, the threshold cycle value was a linear function of the starting complementary DNA 
input over a wide dynamic range. Results, expressed as N-fold differences in target gene 
expression relative to β-actin gene and termed Ntarget, where the ΔCt value of the sample 
was determined by subtracting the average Ct value of the target gene from the average Ct 
value of the β-actin gene. Ntarget values of the samples were subsequently normalized, such 
that the median of the 5 normal stomach Ntarget values was 0.95 to 1. TaqMan primers 
(MWG, Ebersberg, Germany) and probes (Applied Biosystems, Weiterstadt, Germany) were 
designed to span exon junctions or to lie in different exons to prevent amplification of 
genomic DNA. Primer and probe sequences are shown in Table 1. Probes were labeled with 
the reporter dye FAM at the 5′ and the quencher dye TAMRA at the 3′ end. β-actin primers 
and probes were chosen to lay in introns and are referred to as β-actin–DNA primer or probe 
in Table 3.1. For each primer pair we performed no-template control and no-RT control (RT 
negative) assays, which produced negligible signals that were usually greater than 40 in Ct 
value, suggesting that primer-dimer formation and genomic DNA contamination effects were 
negligible. Experiments were performed with duplicates for each data point. 
 
 
 
 
 27
                                                                                                    Animals, Material and Methods 
Mastermix:   12.5 µl QPCR-Mix  
                      0.5 µl forward primer (25.0 µM) 
                      0.5 µl reverse primer (25.0 µM) 
                      0.5 µl probe (6.0 µM) 
                      6.0 µl bidistilled water 
                      5.0 µl unknown/standard 
 
 
PCR amplification 
 
All PCR reactions were performed using a ABI Prism 7700 Sequence Detection System 
(Perkin-Elmer Applied Biosystems, Oak Brook, IL). PCR was performed using the QPCR- 
Mix Reagents kit (ABgene) and 0.5 µl of a 6.0 µM probe. The thermal cycling conditions 
comprised an initial denaturation step at 95°C for 10 min and 40 cycles at 95°C for 15 sec and 
65°C for 1 min. 
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Table 3.1 Sequences of Primers and Probes Used for Real-Time Quantitative PCR or 
RT-PCR  
Mouse β-actin 
Forward primer 
Reverse primer 
Fluorogenic probe 
5′-CGTGAAAAGATGACCCAGATCA-3′ 
5′-CACAGCCTGGATGGCTACGT-3′ 
5′-TTTGAGACCTTCAACACCCCAGCCA-3′ 
Mouse IL-
12Rβ2 
Forward primer 
Reverse primer 
Fluorogenic probe 
5′-ACCTGAGCTCTGCGAAATTCA-3′ 
5′-CCTGGGCTGTAGGCTGCTT-3′ 
5′-TACCGACGCTCTCAAAACTCACATCCAA-3′ 
Mouse IFN-γ 
Forward primer 
Reverse primer 
Fluorogenic probe 
5′-CAGCAACAGCAAGGCGAAA-3′ 
5′-CTGGACCTGTGGGTTGTTGAC-3′ 
5′-AGGATGCATTCATGAGTATTGCCAAGTTTGA-3′ 
Mouse IL-4 
Forward primer 
Reverse primer 
Fluorogenic probe 
5′-CGCCATGCACGGAGATG-3′ 
5′-CGAGCTCACTCTCTGTGGTGTT-3′ 
5′-TGCCAAACGTCCTCACAGCAACG-3′ 
Mouse IL-12A 
Forward primer 
Reverse primer 
Fluorogenic probe 
5′-ACTAGAGAGACTTCTTCCACAACAAGAG-3′ 
5′-GCACAGGGTCATCATCAAAGAC-3′ 
5′-AGCTGCCTGCCCCCACAGAAGA-3′ 
Mouse IL-12B 
Forward primer 
Reverse primer 
Fluorogenic probe 
5′-CTACAGCACCAGCTTCTTCATCA-3′ 
5′-TCAAAGGCTTCATCTGCAAGTTC-3′ 
5′-CATCATCAAACCAGACCCGCCCA-3′ 
Mouse TNF-α 
Forward primer 
Reverse primer 
Fluorogenic probe 
5′-CATCTTCTCAAAATTCGAGTGACAA-3′ 
5′-CCAGCTGCTCCTCCACTTG-3′ 
5′-CCTGTAGCCCACGTCGTAGCAAACCA-3′ 
Mouse IL-6 
Forward primer 
Reverse primer 
Fluorogenic probe 
5′-ACAAGTCGGAGGCTTAATTACACAT-3′ 
5′-TTGCCATTGCACAACTCTTTTC-3′ 
5′-TTCTCTGGGAAATCGTGGAAATG-3′ 
Mouse IL-10 
Forward primer 
Reverse primer 
Fluorogenic probe 
5′-CCAGAGCCACATGCTCCTAGA-3′ 
5′-GGTCCTTTGTTTGAAAGAAAGTCTTC-3′ 
5′-CTGCGGACTGCCTTCAGCCAGG-3′ 
Mouse BTC 
Forward primer 
Reverse primer 
Fluorogenic probe 
5’-TTCGTGGTGGACGAGCAA-3’ 
5’-TCACACCGAGCCCCAAAG-3’ 
5’-CTCCCTCCTGCATCTGTGAGAAAGGCT-3’ 
Mouse TGFα 
Forward primer 
Reverse primer 
Fluorogenic probe 
5’-CGGTTTTTGGTGCAGGAAGA-3’ 
5’-TCACAGCGAACACCCACGTA-3’ 
5’-AGCCAGCATGTGTCTGCCACTCTGG-3’ 
*Cyclophillin 
Forward primer 
Reverse primer 
 
5’-ATGGTCAACCCCACCGTGT-3’ 
5’-TTCTGCTGTCTTTGGAACTTTGTC-3’ 
*Amylase2 
Forward primer 
Reverse primer 
 
5’-TGGTCAATGGTCAGCCTTTTTC-3’ 
5’-CACAGTATGTGCCAGCAGGAAG-3’ 
*Elastase 
Forward primer 
Reverse primer 
 
5’-GGCTCCTCTGTGAAGAATACCA-3’ 
5’-TACTGACCGTTCACCATGCA-3’ 
*CK19 
Forward primer 
Reverse primer 
 
5’-ACCCTCCCGAGATTACAACCA-3’ 
5’-GGCGAGCATTGTCAATCTGT-3’ 
* Quantitative PCR was performed with SYBR® green.  
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3.5.6 Real-time RT-PCR with SYBR® Green 
 
Quantitative values are obtained from the threshold cycle number at which the increase in the 
signal associated with exponential growth of PCR products begins to be detected using PE 
Biosystems analysis software, according to the manufacturer’s manuals. The precise amount 
of total RNA added to each reaction mix (based on optical density) and its quality (i.e., lack of 
extensive degradation) are both difficult to assess. We therefore also quantified transcripts of 
the house keeping gene coding Cyclophillin as the endogenous RNA control, and each sample 
was normalized on the basis of its Cyclophillin content. Final results, expressed as N-fold 
differences in target gene expression relative to the Cyclophillin gene were determined as 
follows: Ct values of the sample are determined by subtracting the average Ct value of the 
target gene from the average Ct value of the Cyclophillin gene.  
 
Primers and PCR consumables 
 
Primers for the Cyclophillin and target genes were chosen with the assistance of the computer 
programs Oligo 4.0 (National Biosciences, Plymouth, MN). The nucleotide sequences of the 
oligonucleotide hybridization primers are shown in Table 3.1. To avoid amplification of 
contaminating genomic DNA, 1 of the 2 primers was placed in different exons.  
 
PCR amplification 
 
All PCR reactions were performed using a ABI Prism 7700 Sequence Detection System 
(Perkin-Elmer Applied Biosystems, Oak Brook, IL). PCR was performed using the SYBR® 
Green PCR Core Reagents kit (Perkin-Elmer Applied Biosystems). The thermal cycling 
conditions comprised an initial denaturation step at 95°C for 10 min and 40 cycles at 95°C for 
15 sec and 65°C for 1 min. 
 
 
Mastermix:    12.5 µl SYBR® MM buffer 
                      2.25 µl forward primer (900 nM) 
                      2.25 µl reverse primer (900 nM) 
                        3.0 µl bidistilled water 
                        5.0 µl unknown/standard 
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3.5.7 In situ hybridization 
 
3.5.7.1 Generation of probes for in vitro transcription 
 
A digest was performed of 10 µg pTOPO plasmid containing the mouse BTC-cDNA with the 
appropriate restriction enzyme (NotI).  
 
Digest:    DNA                             10 µg 
               10x buffer                      10 µl 
               NotI                            30 units 
               bidistilled water up to  100 µl 
 
Digest was incubated for more than 3 hours at 37°C. The DNA was extracted by using GE 
Healthcare DNA purification columns by following the manufacturer’s protocol. Complete 
DNA linearization was confirmed by agarose gel electrophoresis and ethidium bromide 
staining. 
 
3.5.7.2 In vitro transcription reaction 
 
The linearized DNA was transcribed into RNA. 
 
2 µg of linearized DNA 
4 µl transcription buffer 
2 µl of 0.1 M DTT 
2 µl Dig RNA labeling mix 
1 µl RNase inhibitor 
1.5 µl T7 or T3 or SP6 RNA polymerase 
bidistilled water up to 20 µl  
 
The mix was incubated for more than 2 hours at 37°C. After transcription 1 µl DNase was 
added to the mix and further incubation took place for 10 min at 37°C. The RNA was purified 
by using the RNeasy Kit (Quiagen) by following the manufacturer’s protocol. The RNA was 
eluted in 50 µl water and 50 µl formamide and stored at –20°C. 
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3.5.7.3 In situ hybridization assay  
 
Fresh tissue was fixed over night at 4°C. At the next the tissue was washed two times for 10 
min in PBT, and dehydrated in 25 %, 50 % and 75% methanol in PBT for 5 minutes each. 
Finally, the tissue was rinsed two times for 5 min in 100 % methanol and then stored in 
methanol at -20°C. 
 
PBT:    PBS 
0.1 % Tween® 20 
 
The tissue was transferred to 100 % ethanol (with two ethanol change steps) and then washed 
three times for 5 min in xylene. The tissue was embedded in paraffin by dehydration through 
several ethanol concentrations (rising up to 100 %). 
Eight µm thick sections were cut with a microtome and mounted on Super Frost Slides. These 
slides were dried over night at 50°C. Sections were hydrated with DEPC treaded water as 
described in 3.6.1. All incubations were done in glass jars previously backed at 200°C over 
night and all reagents were used in separate bottles. Slides were treated with 0.2 N HCl for 15 
minutes. Sections were incubated with proteinase K (30µg/ml) in PBS at 37°C for 20 min. 
Slides were rinsed in PBS with 0.2 % glycine and two times for 5 min in PBS. For post-
fixation the slides were incubated for 10 min in 4 % paraformaldehyde and then rinsed two 
times for 5 min in PBS. The sections were treated with acetic anhydride solution 5 min twice 
before being washed two times in PBS. 
 
Acetic anhydride solution:  triethanolamine    670 µl 
                                            DEPC-water          50 ml  
                                            acetic anhydride   300 µl 
 
Slides were rinsed again in PBS for two times and two times for 5 min with 5xSSC (pH 4.5). 
For prehybridization, the slides were placed in a box humidified with 5xSSC in 50 % 
formamide and hybridization solution was added to the slides to completely cover the tissue. 
The slide box was incubated in a 70°C oven for at least 1 hour. 
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Hybridization solution:  5xSSC 
                                       formamide              50 % 
                                       block powder            2 % 
                                       EDTA                     5mM 
                                       Chaps                    0.05 % 
                                       heparin              50 mg/ml 
                           yeast total RNA 50 µg/ml 
 
Prehybridization solution was replaced with hybridization solution containing 500 ng/ml of 
probe and incubated at 68°C for 24-72 hours in the humidified chamber. For post-
hybridization washes, the slides were rinsed for 5 min in 2xSCC pH 4.5 and following three 
times for 30 min at 65°C in  2xSCC pH 4.5 in 50 % formamide and then in five times for 5 
min in TBST. 
For immunological detection, the sections were first blocked for 30 min in TBST with 1 % 
sheep serum and 0.5 % blocking powder. The blocking solution was decanted and incubated 
with sheep anti-digoxigenin Fab antibody (Roche, Mannheim) diluted 1/2000 in blocking 
solution over night at 4°C. On the next day the slides were washed five times for 5 min in 
TBST and then three times for 5 min in NTM. 
 
NTM:  Tris pH 9.5   0.1 M 
            MgCl2         0.05 M 
            NaCl             0.1 M 
 
The slides were incubated overnight with NBT/BCIP in the dark. 
 
NBT: dissolve 10 mg tablet in 1 ml bidistilled water and protect from light 
BCIP: dissolve 25 mg tablet in 500µl dimethylformamide and protect from light 
 
NBT/BCIP:    NTM buffer        15 ml 
                       NBT                   500µl 
           BCIP                    52 µl 
                      1 M levamisole  37.5 µl 
 
 
On the next day sections were washed in bidistilled water and the tissue was dehydrated and 
covered with cover slides as described in 3.6.1. 
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3.6 Analysis of transgenic mice 
 
Mice were anesthetized with ether and were bled from retroorbital eye sinus. After 
measurement of the distance between nose and the base of the tail (nose-rump-length, NRL), 
they were killed by cervical dislocation. Organs were removed, blotted dry on a paper towel 
and weighed to the nearest mg with a scale. Parts of organs were frozen on dry ice for protein 
or RNA isolation or fixed for histological investigation in 4 % paraformaldehyde solution. 
Blood samples were centrifuged in 1.5 ml centrifuge tubes in a 4°C cooled table top 
centrifuge at 4000 rpm for 10 min to and serum was stored at -20°C until use.  
For the histological visualization of proliferating cells, mice were injected i.p. with BrdU (30 
mg/kg body weight) two hours before sacrifice. BrdU is incorporated by nuclei of S-phase 
cells and reflects the proliferation rate. The organs were obtained and processed as described 
above.  
 
3.7 Histological analysis 
 
Tissues or organs were fixed for 24 h in 4 % paraformaldehyde solution at 4°C. Fixed tissue 
was dehydrated through a rising alcohol row and embedded in paraffin.  
 
4 % paraformaldehyde solution:      PBS 
                                                         paraformaldehyde          4 %  
                                                         5 M NaOH              0.025 % 
 
Heat the solution up to 50°C until the paraformaldehyde powder is dissolved, and than adjust 
the pH to 6-7 with HCl (Merck, Darmstadt, Germany). 
 
Histological sections were cut with a microtome at a nominal thickness of 3 µm, stained with 
hematoxylin/eosin (HE) and periodic acid-Schiff (PAS). 
 
3.7.1 Hematoxylin/eosin (HE) staining 
 
Prepared sections were deparaffinized for 15 min in xylene and rehydrated through a 
descending alcohol row, for five minutes twice in 100% ethanol, 90% ethanol and one time 
for five minutes in 70% ethanol and than for a short time in distilled water. Sections were 
stained for five minutes in Mayer’s Hemalaun and than rinsed in water for five minutes, 
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before the sections were dipped five times into eosin. After rinsing in distilled water, the 
stained sections were dehydrated through the alcohol row in the opposite direction until the 
xylene step. The tissue was covered with coverquick and a cover slide.  
 
3.7.2 Periodic acid Schiff staining 
 
Tissues were fixed, embedded, deparaffinized and rehydrated as described previously. 
Sections were oxidated for 10 min in periodic acid and than rinsed for 10 min in distilled 
water before staining in a dark place for 30 min in Schiff Reagent at RT. The sections were 
rinsed again for 5 min with distilled water before the nuclei were stained for 2 min with 
Mayer’s Hemalaun. Sections were rinsed in distilled water for 5 min and following 
differentiated for a short time in 0.5 % HCl. After a final rinsing the sections were dehydrated 
and covered as described previously.  
 
Periodic acid:    1. periodic acid     10 g 
                              bidistilled water   1 l 
 
                          2.  natrium acetate        1.6 g 
                              bidistilled water 100 ml 
Both solutions have to be produced separatedly and stored at 4°C. 
 
HCl-ethanol-stock-solution:  96 % ethanol                      700 ml 
                                               bidistilled water                 250 ml 
                                               25 % HCl                             10 ml 
 
0.5 % HCl solution:  HCl-ethanol-stock-solution     100 ml 
                                  70 % ethanol                            100 ml 
 
3.7.3 Immunohistochemical stainings 
 
Tissues were fixed, deparaffinized and rehydrated as described previously. Sections were 
boiled for antigen retrieval two times for 10 min each in a 700 Watt microwave at 95°C in 10 
mM sodium citrate buffer pH 6.0.  
 
Stock citric acid (0.1 mol):  19.2 g citric acid in 1 l bidistilled water 
Stock sodium citrate (0.1 mol):  29.4 g sodium citrate dihydrate in 1 l bidistilled water 
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Working solution:  citric acid (0.1 mol)           27 ml 
                               sodium citrate (0.1 mol)  123 ml 
                               Tween® 20                        1.5 ml 
                               bidistilled water up to    1500 ml 
 
                                
After that the sections were cooled down to room temperature at the bench for 20 min. Before 
blocking the endogenous peroxidase with 3% H2O2 for 15 min, the sections were washed 
shortly in distilled water. Next, sections were washed twice five min in TBS, before blocking 
them for 30 min with serum from the animal in which the second antibody was generated. The 
serum was decanted and than the first antibody was incubated for mostly one hour at the 
sections. The following primary antibodies were used:  
goat anti-betacellulin (1:200 dilution, R&D Systems, Wiesbaden, Germany)  
rabbit anti-ErbB1 and anti-ErbB4 (1:250 dilution, Santa Cruz, Heidelberg, Germany)  
rat anti-BrdU (1:50 dilution, AbD Serotec, Oxford, UK) 
rat anti-Ki67 (1:200 dilution, Dako, Hamburg, Germany) 
mouse anti-TGFA (1:50 dilution, R&D Systems, Wiesbaden, Germany) 
anti-cleaved caspase 3 (1:200 dilution, Cell Signaling,) 
 
Appropriate secondary antibodies were used:  
rabbit anti-rat (1:50 dilution, IgG:HRP, AbD Serotec, Oxford, UK) 
rabbit anti-rat (1:100 dilution, Ig biotinylated, Dako, Hamburg, Germany) 
rabbit anti-goat (1:200 dilution, IgPO, Dako, Hamburg, Germany) 
goat anti-rabbit (1:200 dilution, Ig biotinylated, Vector, Burlingame, USA) 
goat anti-rabbit (1:200 dilution, Ig biotinylated, Dako, Hamburg, Germany) 
goat anti-mouse (1:200 dilution, Ig biotinylated, Dako, Hamburg, Germany) 
 
Sections incubated with a secondary biotin-conjugated antibody for 1 hour were next 
incubated for 30 min with a tertiary complex of streptavidin-biotin conjugated to horseradish 
peroxidase. Otherwise, 3,3’-diaminobenzidine (DAB) (KEN-EN-TEC, Taastrup, Denmark) 
was used as chromogen after one hour incubation with the secondary HRP conjugated 
antibody. 1µl H2O2 was added per milliliter DAB as a starter. Sections were counterstained 
with Mayer’s hematoxylin for one minute. 
 
Control experiments included the omission the first antibody and, for BTC, pre-absorption of 
the first antibody (30 min, 37°C) with increasing amounts of the antigen (recombinant mouse 
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betacellulin, R&D Systems: 2, 4, 8 or 16 ng/ml antigen) to demonstrate the specificity of the 
signal.  
 
 
3.8 Evaluation of proteins 
 
3.8.1 Extraction of protein from tissues 
 
Tissue samples stored at -80°C were weighed, placed in 5 ml plastic tubes and homogenized 
by 23500 rpm in protein extraction buffer with a tissue homogenizer for 1 minute. For 20 mg 
tissue, 500 µl extraction buffer were used. The homogenizer was cleaned after each sample 
with PBS.  
 
5x Laemmli buffer:               1M Tris (pH 6.8)         65.5 ml      
                                              glycerol                         100 ml 
                                              0.5M EDTA (pH 8.0)       2 ml 
                                              SDS                                  20 g 
                                              bromphenol blue             0.1 % 
                                              bidistilled water up to   200 ml 
                                  
protein extraction buffer:     1M Tris (pH 7.5)               2ml 
                                             Triton X-100                      2ml 
                                             5x Laemmli buffer           20ml 
                                             bidistilled water               76ml 
 
 
The samples were stored on ice, transferred to 1.5 ml centrifuge tubes, incubated at 95°C for 5 
min, chilled on ice for 10 min and centrifuged at 13000 rpm, 4°C, for 5 min. 10µl were 
removed for determination of protein concentration and samples were stored at -20 °C. 
  
3.8.2 Determination of protein concentration 
 
The protein content of samples was estimated by the bicinchoninic acid (BCA) protein assay. 
A set of protein standards of known concentrations was prepared by serially diluting a bovine 
serum albumin (BSA) stock solution (4 mg/ml) in PBS. 50 µl of the standards and of the 
samples of unknown concentration (diluted 1:10 in PBS) were pipetted into 96-well plates and 
200 µl of a mixture of bicinchoninic acid and 4% CuSO4 (50:1) were added to each well and 
mixed. The plate was incubated at 37°C for 30 min and the absorbance was measured at 562 
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nm. A standard curve was prepared by plotting the absorbance of standards versus their 
protein concentration. The protein concentration of the samples was determined using this 
standard curve.  
 
3.8.3 SDS-Polyacrylamide gel electorphoresis (SDS-PAGE) 
 
20 µg of each protein sample were pipetted into centrifuge tubes and filled up with 1x 
Laemmli buffer to the same volume. The samples were incubated at 95°C for 5 min and 
chilled on ice. In some experiments 2-mercaptoethanol was added to the protein samples 
resulting in a final concentration of 5 %. 
The proteins were separated using the Mini Protean® 3 cell system (Bio-Rad). The separating 
gel (12% acrylamide) was prepared in an Erlenmeyer flask under continuous agitation and 
poured into the gap between the glass plates of the system, leaving space enough for the 
stacking gel (about 2.5 cm). The separating gel was overlaid with bidistilled water to ensure 
an even surface.  
 
separating gel (12 %):    bidistilled water                     3.35 ml 
                                       1.5 M Tris (pH 8.8)                  2.5 ml 
                                       30% acrylamide                       4.0 ml 
                                       10% SDS                                 100 µl 
                                       10% ammonium persulfate       50 µl 
                                       Temed                                         5 µl 
 
 
After complete polymerization (45 min) the water was discarded and the stacking gel (5% 
acrylamide) was prepared in the same way and loaded on the top of the separating gel. The 
comb was inserted taking care to not trap air bubbles under the teeth. 
 
 
stacking gel (5 %):       bidistilled water 7.0 ml 
                                     0.5 M Tris (pH 6.8) 1.25 ml 
                                     30% acrylamide 1.5 ml 
                                     10% SDS 100 µl 
                                     10% ammonium persulfate 100 µl 
                                     Temed 5 µl  
 
After complete polymerisation (30 min) the comb was removed and the plates were mounted 
in the electrophoresis apparatus which was filled with SDS-page electrophoresis buffer. 
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SDS-PAGE electrophoresis buffer:     Tris                        30.3g 
                                                             glycine                    144g 
                                                             SDS                          10g 
                                                             bidistilled water up to 1l 
                                                            
Samples were loaded and the electrophoresis was performed initially at 100V for 10 min and 
then at 140V until the bromophenol blue left the separating gel at the bottom. A molecular 
weight standard (PageRulerTM Prestained Protein Ladder #SM0671, MBI Fermentas etc.) was 
pipetted into the first slot for estimation of the protein size. 
 
3.8.4 Electrophoretic blotting  
 
The gel was removed from the electrophoresis chamber and the separated proteins were 
transferred to a PVDF membrane (Millipore) by semidry blotting in an electroblotter (Bio-
Rad). One sheet of gel blotting paper (Bio-Rad) with the same size of the gel was soaked in 
transfer buffer stacked on the bottom of the electrode, and squeezed with a pipette to remove 
air bubbles. The PVDF membrane and then the gel were placed exactly over the paper and 
were covered with another blotting paper. The upper electrode was positioned and the system 
connected to a power supply (Bio-Rad). The transfer took place for 55 min at 15 mA for all 
gels. 
 
10x transfer buffer:    Tris                           58.2g 
                                   glycine                      29.2g 
                                   SDS                            3.7g 
                                   bidistilled water     up to 1l 
 
Methanol was added to the freshly prepared 1x solution to a final concentration of 20%. 
 
After the transfer the membrane was unambiguously labelled with a pen, stained with 
Ponceau S solution for 5 min, and rinsed with distilled water. Air-dried membranes were 
stored at 4°C.  
 
3.8.5 Detection of the antigen 
 
The membrane was rinsed for 1 min in methanol and than rinsed 3 times for 5 min in TBS-T 
buffer on a seesaw at RT.  
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10x TBS buffer:       Tris                          30 g 
                                 NaCl                        80 g 
                                 bidistilled water up to 1 l  
 
 
TBS-T buffer:    1x TBS 
                           0.1 % Tween 20 
 
The membrane was incubated in blocking solution at RT for 60 min. 
 
blocking solution:    5 % instant skimmed milk powder  
                                 TBS-T 
 
 
After blocking, the primary antibody was diluted in blocking solution or in 5% BSA diluted in 
TBS-T. When BSA was employed, the membrane was washed 4 times for 5 min at RT in 
TBS-T before being incubated with the antibody. The incubation took place over night on a 
seesaw at 4°C. At the next day the membrane was washed 3 times for 5 min at RT with TBS-
T. Incubation with the secondary antibody diluted in blocking solution was carried out for 1 
hour. After incubation the membrane was washed 3 times for 5 min at RT. Detection was 
performed by incubating the membrane with 2 ml of the ECL Western blotting detection 
reagent (RPN 2106) (GE Healthcare). The membrane was sealed under plastic and exposed to 
an ECL film (GE Healthcare). 
 
primary antibodies:    goat anti-amylase (C-20) sc-12821 (Santa Cruz, Heidelberg, Germany) 
                                  diluted 1:1000 in 5% milk in TBS-T 
                                   rabbit anti-BAX (554106) (BD) 
                                  diluted 1:1000 in 5% milk in TBS-T 
                                  rabbit anti-Bcl-2 (#2876) (Cell Signaling) 
                                  diluted 1:1000 in 5% BSA in TBS-T 
                                  rabbit anti-Bcl-xL (#2762) (Cell Signaling) 
                                  diluted 1:1000 in 5% BSA in TBS-T 
                                   rabbit anti-c-Jun (#9162) (Cell Signaling) 
                                  diluted 1:500 in 5% BSA in TBS-T 
                                  rabbit anti-Phospho-c-Jun (#9164) (Cell Signaling) 
                                  diluted 1:500 in 5% BSA in TBS-T 
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                                  rabbit anti-Phospho-SAPK/JNK (#9251) (Cell Signaling) 
                                  diluted 1:1000 in 5% BSA in TBS-T 
                                  rabbit anti-SAPK/JNK (#9252) (Cell Signaling) 
                                  diluted 1:1000 in 5% BSA in TBS-T 
                                  mouse anti-p-ERK (E-4) sc-7383 (Santa Cruz) 
                                  diluted 1:1000 in 5% BSA in TBS-T 
                                  rabbit anti-ERK 1 (C-16) sc-93 (Santa Cruz) 
                                  diluted 1:1000 in 5% milk in TBS-T 
                                  rabbit anti-ERK 2 (C-14) sc-154 (Santa Cruz) 
                                  diluted 1:1000 in 5% milk in TBS-T 
                                  rabbit anti-Phospho-eIF2α (#9721) (Cell Signaling) 
                                  diluted 1:1000 in 5% BSA in TBS-T 
                                  rabbit anti-eIF2α (#9722) (Cell Signaling) 
                                  diluted 1:1000 in 5% BSA in TBS-T 
                                  rabbit anti-Phospho-p38 MAPK (#4631) (Cell Signaling) 
                                  diluted 1:1000 in 5% BSA in TBS-T 
                                  rabbit anti-p38 MAPK (#9212) (Cell Signaling) 
                                  diluted 1:1000 in 5% BSA in TBS-T 
                                  mouse anti-PARP (556362) (BD) 
                                  diluted 1:1000 in 5% milk in TBS-T 
                                  goat anti-betacellulin (R&D, Germany) 
                                  diluted 1:1000 in 3% milk in TBS-T 
 
 
secondary antibodys:  sheep anti-mouse HRP (NA 931V) (Amersham, Freiburg, Germany) 
                                   diluted 1:1000 in 5% milk in TBS-T 
                                   donkey anti-rabbit HRP (NA 934V) (Amersham) 
                                   diluted 1:1000 in 5% milk in TBS-T 
                                   donkey anti-goat HRP (705-035-003) (Jackson Immuno Research) 
                                   diluted 1:2000 in 5% milk in TBS-T 
                                   rabbit anti-goat HRP sc-12821 (Santa Cruz) 
                                   diluted 1:5000 in 5% milk in TBS-T 
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3.9 Proliferation and apoptosis indices 
 
For the determination of both the proliferation and the apoptosis rate in the exocrine pancreas, 
all immunostained cell nuclei [BrdU-positive (proliferating) or activated caspase-3-positive 
(apoptotic)] present in the pancreas sections from one individual were counted. The numerical 
area density of immunostained exocrine pancreas cell nuclei was obtained by dividing the 
total number of immunostained cell nuclei by the cross-sectional area of the exocrine 
pancreas. The proportion of immunostained exocrine cell nuclei was obtained by dividing the 
numerical area density of immunostained cell nuclei by the numerical area density of exocrine 
cell nuclei. For the planimetrical determination of the numerical area density of exocrine cell 
nuclei a Videoplan Image Processing System (Kontron) coupled to a microscope via a color 
video camera was used. Measurement of the exocrine pancreas area was carried out on images 
displayed on a color monitor. For this purpose, a 25x objective was used providing an 850x 
final magnification. Every 100th visual field covering exocrine pancreas tissue was selected 
for counting of cell nuclei using between the two lines or touching the right-hand lines were 
sampled, while those touching the left-hand line were excluded to give an unbiased sample of 
the exocrine pancreas. The exocrine pancreas area in each visual field was measured by 
tracing its contour with a courser on the digitizing tablet of the image analysis system. Cell 
proliferation and apoptosis indices were defined as the number of immunolabeled cell nuclei 
divided by the number of cell nuclei counted, and expressed as the number of immunolabeled 
cell nuclei / 105 cell nuclei. 
 
3.10 Gastrin RIA 
 
A radioimmunoassay for the quantitative determination of gastrin in human serum (IBL, 
Hamburg) was done. Disposable tubes for γ counter measurements (Sarstedt) and a LB 2111 γ 
counter (Berthold, Bad Wildbad) were used for this approach.  
Gastrin in serum is assayed by a competitive radioimmunoassay using a rabbit antiserum 
raised against a gastrin 6-13 albumin conjugate. Gastrin in standards and samples compete 
with 125I-labelled gastrin-17 in binding to the antibodies. 125I-gastrin binds in a reverse 
proportion to the concentration of gastrin in standards and samples. Antibody-bound 125I-
gastrin is separated from the unbound fraction using the double antibody – polyethyleneglycol 
precipitation technique. The radioactivity of the precipitates is measured. The antiserum used 
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in this assay exhibits crossreaction with gastrin-34 and the sulphated forms of gastrin-17 and 
gastrin-34. The assay was performed according to the manufacturer’s instructions.  
 
3.11 Serum albumin and intragastric pH 
 
Serum was isolated by centrifugation of blood samples obtained under ether anesthesia from 
the orbital plexus with a capillary tube. Serum was diluted 1:10 with bidistilled water and 
albumin levels were measured with a Roche/Hitachi 911 automatic analyzer (Roche 
Diagnostics). The gastric content of 12-16 hours-fasted animals was collected with a pipette 
after opening the stomach with precision scissors immediately after the animal’s death. The 
intragastric pH was measured using pH paper stripes. 
 
3.12 Castration 
 
Castration of 4 week old 5 BTC-tg male mice and their control littermates was performed to 
eliminate testicular hormones. Animals were weighed and anesthetized by i.p. injection of 8 
µl/g of the following anesthetic cocktail:  
 
 
Anaesthesia:  Ketamin (10 %)            1.0 ml 
                      Xylacin (2 %)              0.25 ml 
                      NaCl2 solution (0.9 %)  5.0 ml 
 
                                                         
The skin of the distal abdomen was shaved and desinfected with 70 % isopropanol. A 5 mm 
incision through the skin along the midline about the scrotal sac was done. Another cut of 5 
mm was done through the muscles of the abdomen.  The fat pad which adheres to the testis 
was grasped with blunt forceps and the testis was carefully pulled out. The vas deferens with 
the prominent blood vessel was located and taken off with two ligatures of surgical silk. 
Between both ligatures the vas deferens with the blood vessel were cut with a fine scissor and 
a second cut was done to dissect the testis away from the fat pad. The fat pad was pushed 
back into the scrotal sac and these steps were repeated on the other testis. The muscle layer 
was sewed up with two stitches and the skin was clipped with wound clips. At the end of the 
procedure the mouse was placed in a clean cage and kept warm on a 37°C warming plate until 
it recovered from the anaesthesia. Wound clips were removed after 10 days.  
 43
                                                                                                    Animals, Material and Methods 
3.13 Tissue Collection and Adenoma Scoring 
 
Mice in litters from BTC transgenic × Apc+/Min matings were monitored daily. Individual 
animals showed signs of illness at the age of 5 months and all animals were killed at this time 
point by cervical dislocation. The gastrointestinal tract from duodenum to the rectum was 
immediately removed and flushed with ice-cold PBS to remove faecal material. The small 
intestine was cut into three parts with the same length and the caecum and colon were 
separated. PBS-flushed intestinal segments were cut longitudinally, laid open on Whatmann 
3MM paper, and fixed overnight in 4% PFA. After replacing PFA with 70% ethanol, polyps 
and their diameter were recorded under a dissection microscope. Representative polyps were 
excised together with normal tissue, dehydrated, and embedded in paraffin. The adenoma 
score was performed in a blinded manner.  
 
3.14 Pancreatitis 
 
3.14.1 Caerulein pancreatitis model 
 
This study was performed with two-month-old BTC-tg males and their control littermates. 
The animals were placed in individual cages for 16 h on a grid for fasting, but water was 
available ad libitum. Experiments were carried out in two separate series. In the first series the 
animals underwent a 24-h acute pancreatitis and in the second series the mice underwent a 3-h 
acute pancreatitis. Animals which belonged to the 24-h pancreatitis group were induced (i.p.) 
8 times with caerulein (50 µg caerulein/kg mouse) dissolved in 0.9 % NaCl solution in 1 h 
intervals. After the last caerulein induction the animals received food and were killed 24 h 
later. The 3-h pancreatitis group was induced 2 times with caerulein with 1 h between the 
injections, and 1 h after the last caerulein induction the animals were killed. Blood was 
collected for serum analysis from the retro orbital sinus. The abdomen was opened and the 
pancreas was carefully dissected out. Small samples of three different parts of the pancreas 
were frozen in liquid nitrogen for protein analysis, and small samples for RNA were 
immediately homogenized in RLT buffer (Qiagen) with 1% 2-mercaptoethanol and also 
frozen in liquid nitrogen. The remaining part of the pancreas was fixed in 4 % 
paraformaldehyde at 4°C for 24 h and embedded in paraffin. Serum, protein, cDNA and 
histological section was isolated or done as previously described.  
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3.14.2 Serum analysis 
 
Serum was diluted 1:10 with bidistilled water, pipetted into a centrifuge tube and maintained 
on ice until measuring. Amylase, lipase and LDH were measured in the Institute “Klinische 
Chemie” of the “Klinikum Rechts der Isar”, Munich, Germany.  
 
3.14.3 Histological scoring 
 
A histological score was performed for the three parameters necrosis, inflammation and 
oedema. The embedded pancreas was cut in longitudinal sections five times in a distance of 
25 µm. After staining with H.E., pancreatic slides (3 µm) from caerulein injected BTC-tg 
mice and control mice were graded in a blinded manner (without knowledge of experimental 
group) regarding the severity and extent of edema, inflammatory cell infiltration and acinar 
necrosis. 20 visual fields of each surface of the slides were selected, so that 100 visual fields 
of every animal were evaluated. For investigation of inflammation and necrosis a 400x 
magnification and for edema a 50x were used. The following standardized scoring system was 
applied. 
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Histopathologic scoring criteria: 
 
Edema: 
0 = absent 
0.5 = focal expansion of interlobar septae 
1 = diffuse expansion of interlobar septae 
1.5 = same as 1 + focal expansion of interlobular septae 
2 = same as 1 + diffuse expansion of interlobular septae 
2.5 = same as 2 + focal expansion of interacinar septae 
3 = same as 2 + diffuse expansion of interacinar septae 
3.5 = same as 3 + focal expansion of intercellular septae 
4 = same as 3 + diffuse expansion of intercellular septae 
 
Acinar necrosis: 
 
0 = absent 
0.5 = focal occurrence of 1-4 necrotic cells/HPF 
1 = diffuse occurrence of 1-4 necrotic cells/HPF 
1.5 = same as 1 + focal occurrence of 5-10 necrotic cells/HPF  
2 = diffuse occurrence of 5-10 necrotic cells/HPF  
2.5 = same as 2 + focal occurrence of 11-16 necrotic cells/HPF  
3 = diffuse occurrence of 11-16 necrotic cells/HPF 
3.5 = same as 3 + focal occurrence of >16 necrotic cells/HPF 
4 = >16 necrotic cells/HPF 
 
Inflammation: 
 
0 = 0-1 intralobular leukocytes/HPF 
0.5 = 2-5 intralobular leukocytes/HPF 
1 = 6-10 intralobular leukocytes/HPF 
1.5 = 11-15 intralobular leukocytes/HPF 
2 = 16-20 intralobular leukocytes/HPF  
2.5 = 21-25 intralobular leukocytes/HPF  
3 = 26-30 intralobular leukocytes/HPF 
3.5 = 30-35 intralobular leukocytes/HPF 
4 = >35 intralobular leukocytes/HPF 
 
 
3.15 Statistical analysis 
 
Data are presented as means ± SD and were analyzed for significance of differences 
employing two-tailed Student’s t-tests (GraphPad Prism version 4.00 for Windows, GraphPad 
Software, San Diego California USA). Effects of BTC on the body and organ weights (Table 
1) were analysed by 2-factorial ANOVA (SAS Institute, Inc., Cary, NC). A difference was 
considered to be statistically significant if P < 0.05. 
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3.16 Material 
 
3.16.1 Machines 
Accu-jet® pro pipette controller Brand, Wertheim 
Agarose gel electrophoresis chamber MWG-Biotech, Ebersberg 
Analytical balance Sartorius, Goettingen 
AU 400 autoanalyzer Olympus, Hamburg 
Axiovert 135 microscope Zeiss, Oberkochen  
Benchtop 96 tube working rack Stratagene, La Jolla, USA 
Blunt forceps Aesculap, Tuttlingen 
Bulldog forceps Aesculap, Tuttlingen 
ELISA reader Spectra Max 250 Molecular Devices, Sunyvale, USA 
Fine scissors Aesculap, Tuttlingen 
Gel documentation system Intas, Göttingen 
Glass case for glass rack Roth, Karlsruhe 
Graphite Electroblotter I Millipore, Billerica, USA 
Heating plate with magnetic stirrer IKA process equipment, Staufen 
Hitachi 911 autoanalyzer Roche, Mannheim 
HM 315 microtome Microm, Walldorf 
HomogenizerART  Labortechnik, Müllheim 
Hybridization ovenH.  Saur, Reutlingen 
Incubator Heraeus, Munich 
Labotec thermo-cell-transporter Labotec, Bovenden-Göttingen 
LB 2111 γ-counter Berthold, Bad Wildbad 
Microwave Siemens, Munich 
Mini Protean® 3 Cell Bio Rad, Munich 
MS1 Minishaker IKA process equipment, Staufen 
Multipette®  plus Eppendorf, Hamburg 
NanoDrop-1000 spectrophotometer NanoDrop Technologies, Wilmington, 
   USA 
Needle holder Aesculap, Tuttlingen 
Needle Aesculap, Tuttlingen 
Phosphorimager Storm 860 GE Healthcare, Munich 
Power Pac 300 Bio Rad, Munich 
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Power Supply MWG-Biotech, Ebersberg 
Scintillation counter LS6500 Beckman, Palo Alto, USA 
Staining box according to Schiefferdecker Roth, Karlsruhe 
TaqMan®, Perkin Elmer 7700 Applied Biosystems, Foster City, USA 
Thermomixer 5436 Eppendorf, Hamburg 
UV-Crosslinker Biometra, Göttingen 
Videoplan® image analysis system Zeiss-Kontron, Eching 
Watch maker forceps Aesculap, Tuttlingen 
Wound clips Aesculap, Tuttlingen 
 
Thermocycler: 
Biometra Uno Thermoblock Biometra, Göttingen 
Biometra TProfessional Biometra, Göttingen 
Mastercycler® gradient Eppendorf, Hamburg 
 
Centrifuges: 
Heraeus Megafuge 1.0R Heraeus, Munich 
Rotanta 96 Hettich, Tuttlingen 
Table centrifuge with cooling (5417R) Eppendorf, Hamburg 
 
3.16.2 Consumables 
3-way-Stopcock Fresenius Kabi, Bad Homburg 
Cavafix® Certo® central venous catheter B. Braun, Melsungen 
Centrifuge tubes (15 ml, 50 ml) Falcon®, Becton Dickinson, Heidelberg 
Culture dishes (diameter 10 cm) Nunc, Wiesbaden 
Culture flasks with filter Nunc, Wiesbaden 
Disposable plastic pipettes Falcon®, Becton Dickinson, Heidelberg 
Disposable syringes (2, 5, 10, 20 ml) Codan Medical ApS, Roedby, Denmark 
Disposable tubes for γ-counter Sarstedt, Nümbrecht 
Hybond-N+ Nylon membrane GE Healthcare, Munich 
MicroSpinTM S-300 HR Columns GE Healthcare, Munich 
MillexTM-GP syringe driven filter unit®(0.22 µm)  Millipore, Billerica, USA 
Monovette® blood collection system  Sarstedt, Nümbrecht 
Multi-well plates for cell culture Greiner bio-one, Frickenhausen 
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Parafilm® M American  Can Company, Greenwich, USA 
PCR reaction tubes (0.2 ml) G. Kisker GbR, Steinfurt 
Perfusor® cable (50 cm) B. Braun, Melsungen  
Safe-Lock reaction tubes (1.5 ml, 2 ml) Eppendorf, Hamburg 
Skin adhesive spray A. Albrecht, Aulendorf 
Sterican® cannulas (18 G, 20 G) B. Braun, Melsungen 
Storage phosphor screen Bio Rad, Munich 
Uni-Link embedding cassettes Engelbrecht, Edermünde 
Vasco® OP Protect gloves B. Braun, Melsungen 
Vascocan® indwelling venous catheter B. Braun, Melsungen 
Vicryl (2-0) suture material Ethicon, Norderstedt 
 
3.16.3 Chemicals 
Comment: unless otherwise noted, all chemicals were used in p.a. quality 
 
0.9% NaCl solution B. Braun, Melsungen 
2-Propanol Merck, Darmstadt 
3,3´ diaminobenzidine tetrahydrochloride KemEnTec, Copenhagen, Denmark 
Acetic acid (glacial acetic acid) Roth, Karlsruhe 
Acetic anhydride  Roth, Karlsruhe 
Acrylamide 30% Bio Rad, Munich 
Agar, granulated Difco, Detroit, USA 
Agarose Invitrogen, Karlsruhe 
Ammonium persulfate Bio Rad, Munich 
Ampicillin AppliChem, Darmstadt 
Bacto™ Trypton BD, Heidelberg 
Bacto™ Yeast Extract Difco, Detroit, USA 
Bicinchoninic acid Sigma, Deisenhofen 
Bovine serum albumine Sigma, Deisenhofen 
Bromodeoxyuridine Roche, Mannheim 
Bromophenolblue Serva, Heidelberg 
Chaps  Sigma, Deisenhofen 
Chloroform Merck, Darmstadt 
Citric acid  Merck, Darmstadt 
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D-(+)-glucose Sigma-Aldrich, Deisenhofen 
DEPC (Diethylpyrocarbonate) Sigma, Deisenhofen 
Diethylether Roth, Karlsruhe 
Dimethylformamide  Roth, Karlsruhe 
Disodiumhydrogenphosphate Merck, Darmstadt 
DTT (100 mM) Invitrogen, Karlsruhe 
EDTA Merck, Darmstadt 
Eosin Merck, Darmstadt 
Ethanol Roth, Karlsruhe 
Ethidiumbromide (solution: 1 %) Merck, Darmstadt 
Formaldehyde solution, 37% Sigma-Aldrich, Deisenhofen 
Formamide  Roth, Karlsruhe 
Glycerine Roth, Karlsruhe 
Hydrochloric acid (1 N) Merck, Darmstadt 
Hydrochloric acid (25%) Merck, Darmstadt 
Hydrogen peroxide 35% Roth, Karlsruhe 
Kalium chloride Merck, Darmstadt 
Kaliumdihydrogenphosphate Merck, Darmstadt 
Levamisole  Sigma-Aldrich, Deisenhofen 
Magnesium chloride (25 mM) Qiagen, Hilden 
Magnesium chloride Merck, Darmstadt 
Magnesium sulphate Merck, Darmstadt 
Mayer’s Hämalaun Merck, Darmstadt 
Methanol Merck, Darmstadt 
Milk powder Roth, Karlsruhe 
MOPS Roth, Karlsruhe 
perjodic acid Merck, Darmstadt 
Ponceau S solution Sigma, Deisenhofen 
Schiffsches Reagent Merck, Darmstadt 
Sodium chloride Merck, Darmstadt 
Sodium citrate dihydrate  Merck, Darmstadt 
Sodium hydroxide Roth, Karlsruhe 
Sodiumacetate-trihydrate Merck, Darmstadt 
Sodiumdodecylsulphate Merck, Darmstadt 
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Temed Bio Rad, Munich 
Tris-(hydroxymethyl)-aminomethane Roth, Karlsruhe 
Triton X Roth, Karlsruhe 
Tween® 20 Sigma, Deisenhofen 
X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside)Invitrogen, Karlsruhe 
Xylol SAV LP, Flintsbach a. Inn 
 
3.16.4 Drugs, enzymes and other reagents 
 
3.16.4.1 Drugs 
hCG (Ovogest®) Intervet, Unterschleißheim 
Heparin-Sodium (25.000 IE/5 ml) B. Braun, Melsungen 
Ketamine hydrochloride (Ursotamin®) Serumwerk Bernburg, Bernburg 
Metamizol-Sodium (Vetalgin®) Intervet, Unterschleißheim 
PMSG (Intergonan®) Intervet, Unterschleißheim 
Xylazine (Xylazin 2%) WDT, Garbsen 
 
3.16.4.2 Enzymes 
BamHI MBI Fermentas, St. Leon-Rot 
DNase I (10 U/µl) Roche, Mannheim 
EcoRI MBI Fermentas, St. Leon-Rot 
Herculase® enhanced DNA Polymerase Stratagene, La Jolla, USA 
HotStar Taq Polymerase (5 U/µl) Qiagen, Hilden 
Lamda/HindIII+EcoRI marker MBI Fermentas, St. Leon-Rot 
Proteinase K (20 mg/ml) Roche, Mannheim 
Restriction enzymes and –buffers Fermentas, St. Leon Roth 
Restriction enzymes and –buffers New England Biolabs, Boston, USA 
Ribonuclease A (RNase-A) (0.2 U/µl) Roche, Mannheim 
RNase-Inhibitor (20 U/µl) Applied Biosystems, Foster City, USA 
Superscript™ II Reverse Transcriptase (200 U/µl) Invitrogen, Karlsruhe 
T4 DNA Ligase (2000 U/µl) MBI Fermentas, St. Leon-Rot 
Taq Polymerase (5 U/ml) Qiagen, Hilden 
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3.16.4.3 Other reagents 
10 x ligation buffer MBI Fermentas, St. Leon Roth 
10 x PCR buffer Qiagen, Hilden  
5 x first strand buffer Invitrogen, Karlsruhe 
Block powder  Roche, Mannheim 
dNTPs (dATP, dCTP, dGTP, dTTP) MBI Fermentas, St. Leon-Rot 
Blood & Cell Culture DNA Midi Kit Qiagen, Hilden 
Caerulein  Sigma, Deisenhofen 
Coverquick® Labornord, Mönchengladbach 
ECL western blotting detection reagent Amersham, Freiburg 
Gastrin RIA IBL, Hamburg 
Gel blotting paper (GB002) (Whatman-paper) Schleicher  & Schüll, Dassel 
Gentamycine sulphate Sigma-Aldrich, Deisenhofen 
Jetquick Gel extraction Spin Kit Genomed, Löhne 
Lamb serum Invitrogen, Karlsruhe 
Linear acrylamide (5 mg/ml) Ambion, Austin, USA 
Liquid  nitrogen  Linde, Munich 
Micro haematocrit tubes  Brand, Wertheim 
PageRulerTM Prestained Protein Ladder #SM0671 MBI Fermentas, St. Leon Roth 
pCR®II-TOPO cloning vector Invitrogen, Karlsruhe 
pH paper stripes Macherey-Nagel, Düren 
pUC mix marker MBI Fermentas, St. Leon-Rot 
PVDF-membrane Immobilon-P Millipore, Billerica, USA 
QIAquick® Spin Miniprep Kit Qiagen, Hilden 
QPCR-Mix ABgene, Hamburg 
Q-solution Qiagen, Hilden 
Rabbit serum MP Biomedicals, Illkirch, France 
RNAeasy Kit 50 Qiagen, Hilden 
Random Primers (3 mg/µl) Invitrogen, Karlsruhe 
Rapid-Hyb buffer GE Healthcare, Munich 
Recombinant mouse betacellulin R&D Systems, Wiesbaden 
Saran plastic film Dow Chemical Company  
surgical silk SMI, Hünningen, Belgium 
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SYBR Green PCR MasterMix Applied Biosystems, Foster City, USA 
TOP 10 chemically competent E. coli Invitrogen, Karlsruhe 
TRIZOL Reagent Invitrogen, Karlsruhe 
Vet-Sept® solution (10%) A. Albrecht, Aulendorf 
Wizard® Genomic DNA Purification Kit Promega, Mannheim 
X-ray film Amersham, Freiburg 
α[32P]dCTP GE Healthcare, Munich 
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4. RESULTS 
 
 
4.1. BTC transgenic mice 
 
 
4.1.1 Generation of transgenic mouse lines  
 
The betacellulin cDNA was cloned downstream of the chicken-β-actin promoter and upstream 
of a β-globin poly A signal (Fig. 4.1 A). Pronuclear microinjection was performed in 
fertilized oocytes from the inbred strain FVB/N (Taketo et al. 1990), resulting in the birth of  
potentially transgenic founder animals (n=84). DNA was isolated from tail clips and PCR 
analysis revealed the presence of 3 transgenic mice (data not shown). These animals were 
subsequently mated to control FVB/N females to establish the three transgenic mouse lines 
(L2, L4 and L5). Southern blot analysis revealed different integration sites for each line (Fig. 
4.1 B). In L5, the transgene appears to be linked to the X-chromosome since its transmission 
through males is restricted to female offspring (data not shown). Thus, to avoid complications 
related to the transmission pattern and expression levels (due to functional mosaicism in 
transgenic females), animals from L2 and L4 were used for further studies. Similar alterations 
were observed in these two independent transgenic lines carrying the transgene at different 
integration sites, indicating that the effects described in the following sections are indeed the 
consequence of increased BTC expression and not caused by random integration events.  
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A
 
 
 
 
 
Fig. 4.1 (A) Construct structure and integration properties. Schematic of the betacellulin 
overexpression construct. CMV-IE, immediate early cytomegalovirus enhancer. (B) Southern 
blot of genomic DNA digested with NcoI and probed with betacellulin cDNA confirms three 
different construct integration sites in each line of transgenic mice. The endogenous 
betacellulin restriction fragments migrate at ~8, ~3.5 and ~2.8 kb. The construct-specific 
fragment migrates at ~1.8 kb (arrow). Reproduced from Schneider et al., 2005. 
 
4.1.2 Expression study 
 
Two transgenic and two control mice at the age of 9 weeks from both lines were selected for 
expression studies. Northern blot analysis revealed that the transgene-specific Btc mRNA (~ 1 
kb) was expressed in the small intestine, kidney, liver, spleen, thymus, heart, lung, brain  and 
testes of L2 animals. The endogenous Btc mRNA (~3 kb) had a much weaker intensity as 
wt    tg    wt    tg    wt    tg
L2           L4           L5 
10 kb - 
8 kb - 
6 kb - 
5 kb - 
4 kb - 
3.5 kb - 
3 kb - 
2.5 kb - 
2 kb - 
BTC cDNA CMV IE enhancer / chicken 
β-globin 
β-actin promoter poly A
500 bp 
Nco I Nco I 
Sal I Hind III 
B 
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compared to the transgene-derived mRNA (Fig. 4.2). Figure 4.3 shows representative Western 
blots of protein extracts from heart, lungs, pancreas and eyes of transgenic and control mice 
from lines 2 and 4.  
 in     ki     li    sp    th    he    lu    br   te 
  
~3 kb – 
~1 kb – 
28 S – 
 
Fig. 4.2 Expression of the transgene. Northern blot showing the abundant expression of 
transgene-derived Btc mRNA (~1 kb) as compared to the endogenous Btc mRNA (~3 kb). 
The ethidium bromide-stained 28S ribosomal RNA demonstrates equal loading. in: small 
intestine; ki: kidney; li; liver; sp: spleen; th: thymus; he: heart; lu: lungs; br: brain; te: testes. 
Reproduced from Schneider et al., 2005.  
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Fig. 4.3 A representative result of Western blot analysis showing increased expression of 
betacellulin in heart, lung, eyes and pancreas of transgenic mice from L2 and L4. ey: eyes; pa: 
pancreas. Reproduced from Schneider et al., 2005. 
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4.1.3 Analysis of body and organ weight 
 
BTC transgenic mice from L2 exhibited reduced body weight gain from early postnatal life in 
both genders (Fig. 4.4). As a result, body weight (Fig. 4.5A), nose-rump-length (NRL) (Fig. 
4.5B) and relative NRL (Fig. 4.5C) were significantly reduced at 9 weeks of age. Growth 
reduction was similar in transgenic animals from L4. Their body weight at the age of 9 weeks 
was significantly reduced and the same was true for the NRL and relative NRL (data not 
shown). 
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Fig.4.4 Postnatal growth curves of mice from L2. Reduction in body weight of transgenic 
females (n = 7) as compared to control females (n = 9) was significant during the whole 
observation period. In males, the reduction in weight of transgenic mice (n = 7) as compared 
to control littermates (n = 9) was significant during the whole recorded period except for days 
39-45. Reproduced from Schneider et al., 2005. 
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Fig. 4.5 Significant reduction of body weight (A), nose-rump-length (NRL; B) and relative 
nose-rump length (RNRL; C) in transgenic males (n = 8) and females (n = 9) from L2 as 
compared to gender-matched control littermates (n = 10 for each gender). RNRL was 
calculated as NRL/body weight1/3 to keep the same dimension. *: P<0.05; **: P<0.01; ***: 
P<0.001. Reproduced from Schneider et al., 2005. 
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To detect possible tissue-specific effects of the higher than normal BTC levels, transgenic 
mice and control littermates were killed at the age of 9 weeks and their organs were weighed. 
In spite of the significantly reduced body weight of BTC transgenic mice, only pancreas and 
kidneys were reduced in weight as compared to controls. The reduction of kidney weight was 
proportionate to body weight, whereas pancreas weight was overproportionately decreased 
(Table 1).  
The absolute weights of several other organs were either unchanged or increased in BTC 
transgenic mice. For the weights of eyes, lung and spleen the increase reached statistical 
significance. The relative weights of these organs as well as those of liver, heart and ovaries 
were also significantly increased in Btc overexpressing mice. In contrast, BTC transgenic 
mice exhibited significantly reduced absolute and relative carcass weights (Table 1). The 
carcass is composed of muscle, bone, fat and connective tissue and comprises a large portion 
of total body weight. 
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Table 1 
Absolute and relative organ weights of control and betacellulin-transgenic mice at the age of 9 
weeks 
 
 Weight (mg)  % Body weight  
 wt tg Δ wt tg Δ 
Liver 1342  (47)    1323  (51) - 5.37 (0.12) 6.06 (0.13) ***
Kidneys 367  (11) 323  (11) ** 1.46 (0.04) 1.46 (0.04) - 
Eyes 40  (1.2) 51  (1.4) *** 0.16 (0.07) 0.23 (0.08) ***
Heart 122  (5.0) 134  (5.0) - 0.49 (0.03) 0.63 (0.03) ** 
Lungs 145  (27) 285  (29) ** 0.59 (0.15) 1.37 (0.16) ** 
Spleen 106  (5.0) 130  (6.0) ** 0.43 (0.02) 0.60 (0.02) ***
Pancreas 227  (11) 164  (12) *** 0.91 (0.04) 0.75 (0.05) * 
Testes 177  (7.1) 155  (7.9) - 0.65 (0.02) 0.66 (0.03) - 
Ovaries 9.7  (1.1) 13.0  (1.2) - 0.04 (0.004) 0.06 (0.004) ** 
Carcass 9510 (170) 7880 (190) *** 38.3 (0.5) 36.2 (0.5) ** 
 
The table shows least squares means calculated for BTC transgenic (tg, n=17) and wild-type 
(wt, n=20) mice, taking the effect of gender into account. Standard errors of least squares 
means are shown in brackets. ANOVA was used to show the absence (-) or presence (*: 
P<0.05; **: P<0.01; ***: P<0.001) of a statistically significant difference (Δ) between tg and 
wt mice. Reproduced from Schneider et al., 2005. 
 
In the course of further breeding, alterations in the growth and physiology of several organs 
were detected. In the next chapters, the phenotypical characterization of these manifestations 
will be described. 
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4.2 Stomach 
 
 
4.2.1 Stomach weight 
  
Necropsy of BTC transgenic mice and gender-matched littermates at the age of 1.5-13 months 
revealed a dramatic, age-dependent increase in the size and weight of the stomach. The organ 
started to become visibly enlarged at the age of 4-6 months and increased in size steadily, 
reaching values close to 3 grams in males at the age of 10-12 months (Fig 4.6A). BTC 
transgenic females showed the same pattern of stomach weight increase, although the final 
stomach weight and size were noticeable less pronounced as compared to males (Fig 4.6B). 
 
3 6 9 12
0
500
1000
1500
2000
female control
 
 
Fig 4.6 Age-dependent increase in the stomach weight in BTC transgenic males (A) and 
females (B).  
 
 
Pictures of the stomach from a 10-month-old BTC transgenic male mouse and its control 
littermate demonstrate the dramatic phenotype of this organ (Fig. 4.7). Gross morphologic 
analysis revealed an extraordinarily thickened mucosa, with large projections towards the 
lumen. The projections partially filled the forestomach, resulting in an almost complete 
occlusion of the lumen of this compartment (Fig. 4.7 lower panel).  
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Fig. 4.7 Gross analysis of the stomach from a control (left) and a BTC transgenic (right) 
mouse (littermates, 10-month-old). Note the marked thickening of the transgenic mucosa in 
the sagittal section (bottom picture). Scale bar represents 1 cm. 
 
4.2.2 Northern blot analysis 
 
Northern blot analysis revealed the expression of the Btc mRNA with the expected length of 
1.0 kb in the forestomach and the glandular stomach. A weak expression of the endogenous 
Btc is detected at 3.0 kb. 
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Fig. 4.8 Northern blot showing the transgene-derived BTC mRNA at 1.0 kb and the 
endogenous Btc message at 3.0 kb. Gapdh was used to show equal loading. 
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4.2.3 Stomach pH, albumin and gastrin levels 
 
To investigate the functional consequences of the lesions observed, the pH of the gastric juice 
from BTC transgenic mice and their littermates were measured. In 8-10 months old transgenic 
animals, the gastric pH was close to neutral or in some cases even basic (Fig 4.9A). Serum 
albumin levels were significantly reduced in transgenic mice (Fig 4.9B). Serum gastrin levels 
were not significantly altered in transgenic animals as compared to control littermates (Fig 
4.9C). 
 
 
 
Fig 4.9 The gastric pH is significantly increased in transgenic animals from both genders as 
compared to their control littermates (n=6/group) (A). Serum albumin levels are reduced in 
transgenic mice as compared to control littermates (n=8/group) (B). Serum gastrin levels are 
unchanged in transgenic mice (n=8/group) (C). ***: P < 0.001. 
 
To gain insight into the developmental aspects of the disease, we sacrificed transgenic mice 
and control littermates at different ages and evaluated the morphological changes. 
Histologically, lesions were already present in transgenic mice at the age of 4 weeks and 
consisted of several enlarged cysts found exclusively in the pyloric region (along the lesser 
curvature, Fig. 4.10A). Cell proliferation (determined by BrdU incorporation and 
immunohistochemical staining) revealed that while DNA synthesis occurs mainly in the 
isthmus between the pit and the base of the crypts in non-transgenic mice (Fig. 4.10A), this 
pattern was already perturbed in the 4-weeks-old transgenic stomachs: proliferating cells were 
frequently found at the base of the pits and close to the lumen. Betacellulin immunostaining 
was barely detectable in the stomach of control mice but large amounts of the growth factor 
were detected in transgenic mice, with particularly strong staining close to the base of the 
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crypts (Fig. 4.10A). At the age of two months, the lesions evolved to hyperplastic surface 
epithelium (~ 3 mm) with foveolar cysts in a subcardial localization, while the pyloric mucosa 
was not affected. Mild inflammation was also present (data not shown). At the age of five 
months, the lesions increased in size (~ 5 mm) and were characterized by polypoidal nodular 
regenerative epithelium with numerous foveolar cysts and crypt abscesses (Fig. 4.10B). Cell 
proliferation was vigorous and disorganized and associated with strong BTC levels (Fig. 
4.10B). At the age of 8 months, polyps were even larger (~ 12 mm) and at the age of 12 
months, the lesions reached a size of 15 mm and partially occluded the gastric lumen. At this 
age, foveolar abscesses were increased in size and number, with small lymphocyte 
aggregations. Figure 4.10C illustrates the dramatic size of these late lesions. Cell proliferation 
and BTC levels correlate, showing a patchy distribution within the hyperplastic mass. 
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Fig 4.10 Time course of lesion development in transgenic mice. Since no alterations were 
observed in the fundus, only segments from the antrum are shown. HE staining and BrdU and  
BTC immunohistochemistry for transgenic and control littermates at the age of four weeks, 
five months and one year are shown.  
 
 
Since the hyperplastic lesions invariably originated in the antrum (lesser curvature), while the 
fundus maintained a normal histological appearance, we asked whether this observation was 
related to a specific pattern of transgene expression. In control mice, significant BTC amounts 
were localized close to the pit base along the fundus (Fig. 4.11A), while the antrum showed 
almost no BTC staining (see also Fig. 4.11A). As shown in figure 4.11B, although BTC levels 
were higher in transgenic mice also in the fundus, the distribution or number of proliferating 
cells was not altered (Fig. 4.11B). Thus, the overexpression of BTC specifically in the antrum 
seemed causative for the abnormal growth observed at this location. 
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Fig. 4.11 In non-transgenic mice, BTC is readily localized by immunohistochemistry along 
the greater curvature (arrowheads) while the antrum (large arrow) is negative (A). BTC and 
BrdU staining showing normal distribution of proliferating cells along the greater curvature in 
spite of increased BTC levels (B). 
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4.2.4 Androgen influence of the hyperplasia 
 
To clarify whether the lack of androgens produced by male gonads was the determinant factor 
for the less pronounced stomach weight increase in transgenic females as compared to males, 
a cohort of transgenic males and their non-transgenic gender-matched littermates was 
castrated at the age of 4 weeks and sacrificed at the age of 8 months. The stomach weight of 
castrated males was still significantly higher as compared to castrated control males but 
significantly reduced as compared to the stomach weight of non-castrated BTC transgenic 
males at the same age (Fig. 4.12A). Achlorhydria (Fig 4.12B) was still present, demonstrating 
that gender influences only the degree of the hyperplasia. 
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Fig. 4.12 Stomach weight of not castrated and castrated transgenic male mice and their 
control littermates (A). Stomach pH of castrated BTC male mice and control mice at the age 
of 8 months (B). (n=5/group). ***: P < 0.001. 
 
 
4.2.5 qRT-PCR study 
 
To study the inflammatory process present in the lesions in more detail, quantitative real-time 
PCR was employed to evaluate the mucosal cytokine profile. First, we evaluated Btc 
transcript levels, which were significantly higher in the normal mucosa and in the hyperplastic 
mass of transgenic mice as compared to the control mucosa, as expected (Fig 4.13A). Tgfa 
transcript levels were slightly increased in the unaffected mucosa of transgenic mice (but not 
in the hyperplastic lesions), however, the difference did not reach statistical significance (Fig 
4.13B). The expression of the Th1-type proinflammatory cytokines IL-12 (Fig 4.13C), 
interferon γ (Fig 4.13D) and tumor necrosis factor α (Fig 4.13E) was highly increased in the 
hyperplastic lesions of transgenic mice as compared to the normal glandular mucosa of 
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control animals. Except for IL-12, expression of these cytokines in the lesions was also 
significantly increased as compared to the normal mucosa of the transgenic group. Expression 
of the IL-12 receptor β2 chain (Fig 4.13F) was significantly reduced in the normal transgenic 
mucosa (but not in the pathological area) as compared to control mucosa. Transcript levels of 
the anti-inflammatory cytokine IL-10 (Fig 4.13G) were reduced in the transgenic unaffected 
mucosa but significantly increased in the hyperplastic lesions as compared to the mucosa of 
control mice. IL-4 expression did not change significantly (Fig 4.13H). 
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Fig. 4.13 Quantitative RT-PCR analysis of the expression of Btc, Tgfa, cytokines and T-cell 
markers in the stomach of 4-month-old BTC transgenic and control mice (n=5/group). *: P < 
0.05; **: P < 0.01; ***: P < 0.001. 
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Finally, the gastric alterations of BTC transgenic mice were directly compared with typical 
cases of Ménétrier disease and pyloric gland adenoma (PGA). HE and PAS staining revealed 
that, morphologically, the alterations of BTC mice resembled more closely the changes 
observed in PGA patients than that present in Ménétrier patients (Fig 4.14). In Ménétrier 
disease, proliferative activity (as evaluated by Ki67 staining) is found mainly in the basal 
compartment, whereas PGA show proliferation throughout the lesions, but predominantly 
closes to the surface. BTC transgenic mice almost completely lacked proliferating cells in 
deep gastric glands and showed a rather patchy staining dispersed within the lesion, similar to 
PGA (Fig 4.14). Further, dysplasia or progression to adenocarcinoma was never observed in 
hyperplasia from transgenic mice. BTC immunoreactivity is found in PGA throughout the 
entire epithelium whereas Ménétrier patients show a stromal reaction of some macrophages 
only (Fig 4.14). TGFA shows a partial staining of PGA epithelium whereas in Ménétrier 
disease all columnar epithelium shows a strong reactivity against TGFA (Fig 4.14). 
 69
                                                                                                                                           Results 
 
HE 
PGA BTC TG 
TGFA 
BTC 
Ki67 
PAS 
M. Menetrier
 
Fig. 4.14 Histological evaluation of similarities and differences between Ménétrier disease 
and PGA patients as compared to the lesions observed in the stomach of BTC transgenic 
mice. In addition to the standard HE and PAS staining, immunohistochemistry of Ki67 
(reflecting cell proliferation), BTC and TGFA are shown. 
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4.3 Small and large intestine 
 
 
4.3.1 Weight of the intestine 
 
Differences in intestine size between BTC transgenic and control mice became visible to the 
unaided eye at the age of ~ 8 weeks and increased to be obvious in older animals (Fig. 4.15). 
Quantitative analysis revealed that the small intestine of transgenic mice was significantly 
reduced in length and an increase in weight was detected both in the small and large intestine 
(Table 2). Small intestine villi were significantly narrower and longer in BTC transgenic mice 
as compared to control animals (Table 2 and Fig. 4.15).  
 
 
co tg 
 
Fig. 4.15 Picture from swiss rolls of a control (co) and a BTC transgenic (tg) mouse at the age 
of 12 weeks. Reproduced from Dahlhoff et al., 2008. 
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Table 2. Phenotypic data of BTC transgenic and control littermates at the age of 6 months 
(n=4/group). Data are presented as means ± SD. *: P < 0.05. **: P < 0.01. ***: P < 0.001. 
a Crypts present in 10 mid-jejunal segments (0.5-0.7 mm each) were evaluated; n=2 animals 
per group. Reproduced from Dahlhoff et al., 2008. 
 
 Control Transgenic 
Small intestine   
   Length (cm) 40.6 ± 2.4 33.7 ± 1.8 ** 
   Wet weight  (g) 1.26 ± 0.11 2.00 ± 0.16 *** 
   Villus widtha 100.3 ± 0.4 81.9 ± 1.0* 
   Villus lengtha 204.5 ± 9.3 463.7 ± 2.6** 
Large intestine   
   Length (cm) 7.7 ± 0.7 7.3 ± 0.6 
   Wet weight  (g) 0.290 ± 0.03 0.352 ± 0.06 * 
 
 
 
4.3.2 Histology of the intestine 
 
Analysis of well-oriented histological sections of intestinal rolls revealed a diffuse thickening 
of the mucosa (Fig. 4.17A). Evaluation of PAS-stained histological sections showed a normal 
distribution of goblets cells (Fig. 4.17A). In fact, no changes in the cell distribution along the 
crypt-villus axis could be detected, indicating that the normal pattern of maturation and 
migration of cells is maintained in the intestine of BTC transgenic mice (data not shown). 
Histological evaluation of the intestinal epithelium of control and transgenic animals at 
different ages (up to 12 months) failed to reveal pathological alterations. Western blot 
analysis of transgene-derived BTC (Fig. 4.3) shows expression in the intestine but no 
information was available about its spatial localization. In situ hybridization revealed 
considerably higher amounts of Btc mRNA in the intestinal epithelium and mesenchyme of 
transgenic mice as compared to control animals (Fig. 4.17B). Surprisingly, 
immunohistochemistry revealed that increased BTC protein amounts were present almost 
exclusively in the mesenchyme, while the epithelial cells showed comparatively weaker 
staining (Fig. 4.17B). Immunohistochemical detection of BrdU incorporation revealed a 
greatly expanded zone of proliferating cells in the proliferative activity in the crypts of 
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transgenic mice and quantitative analysis confirmed a significantly higher number of BrdU-
positive cells/crypt in the transgenic group (Fig. 4.17C). 
An interesting alteration was observed in the large intestine of BTC transgenic mice: the 
epithelium surface formed luminal projections resembling small intestinal villi (Fig. 4.16). 
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Fig. 4.16  H.E. staining of the distal (A,B), middle (C,D) and proximal colon (E,F) of a 3-
month-old male control mouse (A,C,E) and an age-matched BTC transgenic mouse (B,D,F).  
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Fig. 4.17 In situ hybridization and immunohistochemical detection of betacellulin in 12-
month-old control and BTC transgenic mice (A). BrdU immunohistochemical labelling of the 
same mice shown in B (B). *: P < 0.05. Reproduced from Dahlhoff et al., 2008. 
 
4.3.3 BTC effects in the intestine are EGFR-dependent 
 
Since BTC is able to activate the ERBB4 receptor in addition to the EGFR, we used a genetic 
approach to evaluate to which extent the mitogenic effect of BTC is mediated by the EGFR. 
Specifically, we crossed BTC transgenic mice to a mouse strain carrying the antimorphic 
allele EgfrWa5, whose product acts as a dominant negative EGFR. The thickening of the 
intestinal mucosa present in BTC transgenic animals was completely abrogated in double 
mutant mice (data not shown). Further, the weight of small and large intestine of double 
mutant mice returned to the levels observed in control or Wa5 animals (Fig. 4.18). Since the 
product of the EgfrWa5 allele selectively inactivates the EGFR, but not the related ERBB2-4 
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receptors, these findings strongly suggest that the phenotypical alterations observed in the 
intestine of BTC transgenic mice are to a large extent, if not completely, mediated by the 
EGFR. 
 
 
Fig. 4.18 Small intestine and large intestine weight of control, Wa5, BTC transgenic and BTC 
transgenic mice carrying the EgfrWa5 allele (n=4/group). *: P < 0.05. **: P < 0.01. Reproduced 
from Dahlhoff et al., 2008. 
 
 
4.3.4 BTC overproduction increases the multiplicity of adenomas in Apc+/Min mice 
 
To test the potential involvement of BTC in tumor formation, we employed the widely used 
Apc+/Min mouse model of intestinal cancer. We introduced the BTC transgene into mice 
carrying a wild-type or a  Apc+/Min allele and monitored the colony on a daily basis. First signs 
of illness were apparent in some animals at the age of 5 months and all mice were killed at 
this age and the total number of polyps and their size were counted. As shown in Fig. 4.19A, 
BTC overproduction had a profound effect on the number of polyps arising in Apc+/Min mice. 
In contrast, we did not detect any effect on mean tumor size (Fig. 4.19B).  
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Fig. 4.19 Polyp number (A) and mean polyp size (B) of 5-month-old Apc+/Min and BTC 
transgenic mice carrying the Apc+/Min allele (n=16 per group). Reproduced from Dahlhoff et 
al., 2008. 
 
To evaluate the Mom1 status of mice used in these experiments, a Mom1 PCR product was 
amplified, digested with BamHI, and separated on an agarose gel (Fig. 4.20); the presence of a 
100 bp and a 400 bp fragment for the Mom1r allele and a 500 bp fragment for the Mom1s 
allele indicated that the genetic background of mice used in this approach contained both 
alleles (Mom1r/s).  
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Fig. 4.20 Agarose gel electrophoresis of PCR products digested with BamHI of progeny from 
BTC transgenic mice mated with Apc+/Min mice. The 500 bp fragment demonstrates the 
Mom1s allele and the 400 bp and 100 bp fragment represent the Mom1r allele containing a 
BamHI restriction site. 
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4.4 Exocrine pancreas 
 
 
4.4.1 Pancreas weight 
 
To confirm the preliminary observation of a significant reduction in the absolute and relative 
pancreas weight of BTC transgenic mice, a larger number of animals were sacrificed at the 
age of 9 weeks and the body weight and absolute pancreas weight were recorded. As shown in 
figure 4.21A, a significantly reduced absolute pancreas weight is present in both genders of 
BTC transgenic mice. Since BTC transgenic mice are smaller and lighter than their control 
littermates, the relative pancreas weight was calculated. As shown in Fig. 4.21B, the relative 
pancreas weight of BTC transgenic mice is also significantly reduced.  
 
Since the pancreas is the only organ of BTC transgenic mice whose absolute and relative 
weight is significantly decreased, further studies were carried out to characterize potential 
histological and functional alterations associated with the reduced organ weight. 
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Fig. 4.21 Absolute (A) and relative (B) pancreas weight of 9-week-old male (n=14/group) and 
female (n=16/group) control and BTC transgenic mice. **: P < 0.01. ***: P < 0.001. 
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4.4.2 Expression of the transgene  
 
Transgene expression in the pancreas has been demonstrated previously by Western blot 
analysis (Fig. 4.3). Immunohistochemistry revealed that in adult (8 weeks of age) control 
mice BTC immunoreactivity was restricted to cells within the islet of Langerhans (Fig. 
4.22A). In BTC transgenic littermates, considerably stronger signals were observed in the 
islets (Fig. 4.22B). More importantly, BTC transgenic mice showed robust, widespread BTC 
immunoreactivity in the exocrine compartment (Fig. 4.22B). 
 
Fig. 4.22 Immunohistochemical localization of BTC in the pancreas of 8-week-old control 
(A) and BTC transgenic mice (B). Scale bars present 50 µm. 
 
BTC expression and localization was also studied during fetal development and early 
postnatal life. BTC was detected in single cells or small clusters in the pancreas of control 
fetuses at embryonic (e) day 15.5 (Fig. 4.23A). In contrast, BTC staining was ubiquitous in 
the pancreatic tissue from transgenic embryos at the same age with some cells showing 
particularly intense staining (Fig. 4.23B). At e17.5 BTC positive cells in control fetuses were 
already organized as larger clusters, probably representing the future islets of Langerhans 
(Fig. 4.23C). In age matched transgenic pancreas samples, BTC staining was present in 
almost all cells, but particularly strong in numerous clusters (Fig. 4.23D). In mice, the 
appearance of typical islets with β-cells in the centre and other endocrine cells in the 
periphery is a very late event, beginning at e18.5 (Herrera et al. 1991). At day 8 of postnatal 
life, Btc-positive cells were restricted to the islets in the pancreas of control animals (Fig. 
4.23E) and present in both endocrine and exocrine compartments in transgenic pancreas 
samples (Fig. 4.23F) resembling the pattern observed in adult animals (Fig. 4.22). 
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Fig. 4.23 Immunohistochemical localization of BTC in the pancreas of control embryos at day 
e15.5 (A), e17.5 (C), postnatal day (P)8 (E) and their BTC transgenic littermates at e15.5 (B), 
e17.5 (D) and P8 (F). Scale bars present 25 µm in panel A-D. Scale bars in panel E and F 
present 50 µm.   
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4.4.3 Pancreas weight gain analysis 
 
In order to gain insight into possible structural alterations of the pancreas, we recorded the 
weight of this organ. In both, males and females, the absolute (Fig. 4.21A) and relative (Fig. 
4.21B) pancreas weight was significantly reduced in transgenic mice as compared to their 
gender- and age-matched controls. 
Since the BTC transgenic mice show an overall reduction in body weight, the question 
remained whether the significant reduction in pancreas weight was intrinsic to this organ or 
much more simply a consequence of the reduced body weight. Therefore, we recorded the 
weight of the pancreas in BTC transgenic and control animals at different ages (range: 3 
weeks – 12 month) and plotted these values against the total body weight (Fig. 4.24). Both 
regression lines go parallel to each other, indicating that BTC exerted its inhibitory effects on 
pancreas weight predominantly during the embryonic development and early postnatal life.    
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Fig. 4.24 Plot of logarithm (ln) of pancreas weight to logarithm (ln) of body weight of control 
and BTC transgenic mice (n=51/group). 
 
 
4.4.4 Proliferation and apoptosis in the pancreas 
 
Cell proliferation in the exocrine pancreas as evaluated by the cell proliferation index (number 
of BrdU-positive cell nuclei/105 cell nuclei) was significantly increased in transgenic mice 
(Fig. 4.25A). The proportion of apoptotic cells (cleaved caspase 3-positive cells) was also 
significantly increased in the exocrine pancreas of transgenic animal compared to control 
animals (Fig. 4.25B). 
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Fig. 4.25  Proliferation index (A) and apoptosis index (B) of 4-month-old male control and 
BTC transgenic mice (n=4/group). *: P < 0.05. **: P < 0.01.  
 
4.4.5 Immunohistochemical localization of EGFR and ERBB4 
 
Since BTC has been reported to directly bind both ERBB1 and ERBB4, the expression of 
these receptors in the pancreas was evaluated by immunohistochemistry. ERBB1 
immunostaining was intensive in the islets and absent in the acinar cells (Fig. 4.26A). 
Notably, the inverse pattern of ERBB4 immunostaining was observed: this receptor was 
easily detectable in the exocrine pancreas and practically absent in the islets (Fig. 4.26B).  
 
 
Fig. 4.26  Immunohistochemical staining of ERBB1 (A) and ERBB4 (B) in control pancreas. 
Scale bars present 50 µm. 
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4.4.6 BTC effects in the exocrine pancreas are EGFR-dependent 
 
BTC transgenic mice were crossed with mutant mice carrying the antimorphic allele EgfrWa5. 
In BTC transgenic mice and double mutant mice, the pancreas weight were significantly 
reduced (Fig. 4.27). This observation strongly suggested that the alterations in the exocrine 
pancreas are not mediated by the EGFR. The high expression of the ERBB4 receptor in the 
exocrine pancreas suggested that ERBB4 possibly mediated the reduction in pancreas weight. 
A Western blot analysis was performed for detecting BTC expression in double mutants. BTC 
transgenic mice and transgenic mice carrying the EgfrWa5 allele show a strong expression of 
BTC in the pancreas (Fig. 4.28).  
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Fig. 4.27 Pancreas weight of 3.5-month-old control, Wa5, BTC transgenic and BTC 
transgenic mice carrying an EgfrWa5 allele (n=3/group). **: P < 0.01. 
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control EGFRWa5 BTC Wa5+BTC positive
 
 
Fig. 4.28 Western blot analysis of BTC expression in control, EgfrWa5, BTC transgenic, BTC 
transgenic mice with EgfrWa5 allele and recombinant BTC as positive control. 
 
 
 
4.4.7 Pancreatitis model induced by caerulein 
 
To functionally evaluate the consequences of BTC excess on the exocrine pancreas, an 
inflammatory model (acute pancreatitis) was employed. 
 
Two different protocols were employed to induce acute pancreatitis. In the first protocol, 
animals received two hourly intraperitoneal injections of caerulein (50 µg caerulein/kg 
mouse) and were killed 3 hours after the first application. In the second protocol, 8 hourly 
caerulein injections were carried out and the mice were killed 24 hours after the first injection. 
In both cases, mice were fasted for 16 hours before the beginning of the experiments. 
Serum amylase and lipase, the first markers for pancreatitis, were measured in control animals 
and in their BTC transgenic littermates with and without pancreatitis. The chemical analysis 
revealed that BTC transgenic mice have lower serum amylase and lipase levels than their 
control littermates (Fig. 4.29). This result suggested that the BTC transgenic mice are less 
affected by the caerulein treatment than the control mice. A Western blot was performed to 
investigate the amylase content of control and BTC transgenic animals in the pancreas (Fig. 
4.30). No alteration was found in both groups of animals, permitting the conclusion that the 
expression of amylase in transgenic animals is not reduced. 
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Fig. 4.29 Serum amylase (A) and serum lipase (B) values of control and transgenic animals 
with 0 hours, three hours and 24 hours of pancreatitis (n=4/group). *: P < 0.05. **: P < 0.01. 
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Fig. 4.30 Western blot of amylase from two-month-old control animals and BTC transgenic 
littermates.  
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Histological scoring was performed by evaluating 50 visual fields per animal for determining 
the grade of necrosis, inflammation and edema. In accordance to the results of the chemical 
analysis (Fig. 4.31), the score of these three histological parameters was significantly reduced 
in BTC transgenic animals as compared to their control littermates (p<0.05) (Fig. 4.31). 
Interestingly, almost no necrotic acinus cells were found in the BTC transgenic group. Fig. 
4.32 demonstrates a representative example of each parameter.  
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Fig. 4.31 Histological score of two month old control mice and BTC transgenic littermates 
with acute 24 hours pancreatitis (n=4/group). *: P < 0.05. 
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A B
C D
E F
Fig. 4.32 Examples of histological sections employed for the scoring of necrosis (A,B), 
inflammation (C,D) and edema (E,F) (H.E.). Picture A, C and E show tissues from a control 
mouse and picture B, D, and F demonstrate a transgenic BTC mouse with acute 24 hour 
pancreatitis. 
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The apoptosis index (expressed as the number of cleaved caspase 3-positive cells/105 cells) 
was significant increased in BTC transgenic mice after acute pancreatitis (3 h) as compared to 
the control littermates (p<0.001) (Fig. 4.33).  
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Fig. 4.33 Apoptosis index of control and BTC transgenic animals with three hours pancreatitis 
(n=4/group). ***: P < 0.001.   
 
Western blot analysis was performed to examine further components of the apoptosis cascade. 
The proteins Bcl-2 and Bcl-xL function as inhibitors of programmed cell death, whereas other 
proteins from the Bcl-2 family like Bax promote apoptosis when they homodimerize or 
heterodimerize with Bcl-2. No alteration could be detected by Western blot analysis in these 
proteins (Fig. 4.34).  
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Fig. 4.34 Western blot analysis of BAX, Bcl-2 and Bcl-xL in pancreas samples from two-
month-old control mice and BTC transgenic mice with and without three hours pancreatitis.  
  
 
 
 87
                                                                                                                                           Results 
Next, expression and phosphorylation levels of several molecules known to be involved in the 
progress of pancreatitis were evaluated. Upon phosphorylation, ERK 1 and 2 dimers influence 
a host of responses including proliferation, differentiation, transcription regulation and 
development. The degree of phospohorylation of both molecules did not differ when BTC 
transgenic mice were compared with control littermates (Fig. 4.36).   
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Fig. 4.35 Densitometry of pJNK2/3 versus JNK2/3 of control and BTC transgenic animals 
tress-activated protein kinase (SAPK), also named Jun-amino-terminal kinase (JNK),  is 
with three hours pancreatitis (n=4/group). *: P < 0.05. 
 
 
S
activated in all kinds of stress including pancreatitis but also by growth factors. Densitometry 
of phosphorylated JNK2/3 revealed that this kinase is significantly more activated in the 
transgenic group with pancreatitis as compared to the control group with pancreatitis (Fig. 
4.35). The phosphorylated SAPK/JNK induces the transcription factor c-Jun which activates 
the gene AP-1. c-Jun will be phosphorylated when JNK binds to its amino-terminal region. 
The activity of c-Jun was investigated in the three hours pancreatitis group. However, no 
increased c-Jun phosphorylation was present in BTC transgenic mice with pancreatitis as 
evaluated by densitometry (Fig. 4.36).  
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Fig. 4.36 Western blot analysis of pancreas tissue from two-month-old control mice and BTC 
transgenic mice with and without three hours pancreatitis. 
 
Under some circumstances, endoplasmic reticulum stress (ER-stress) can induce highly 
increased programmed cell death. To exclude ER-stress as the mechanism behind the reduced 
necrosis observed after induction of pancreatitis in BTC transgenic mice, the eIF2α activity 
was assessed. eIF2α, which α-subunit is phosphorylated by PERK (pancreatic endoplasmic 
reticulum kinase) was examined, but also this signalling cascade was not altered between 
groups as shown by Western blot analysis (Fig.4.37). Similar to JNK, p38 MAP kinase will 
be phosphorylated by a variety of cellular stress including osmotic shock, inflammatory 
cytokines, lipopolysaccharides, UV light and growth factors. But also this initiation factor 
shows no alteration between the control and the BTC transgenic group in three hours 
pancreatitis (Fig. 4.37).  
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Fig. 4.37 Western blot analysis of protein extracts from the pancreas of two-month-old control 
mice and BTC transgenic mice with and without three hours pancreatitis. 
 
Quantitative real-time PCR was employed to evaluate the transcript levels of amylase, CK19 
and elastase. While the amylase and CK19 mRNA levels of control and transgenic animals 
are not altered, the elastase level of transgenic mice is significant lower as compared to the 
control littermates (Fig. 4.38A). However, there is a significant reduction of amylase and 
elastase in the 24 hours pancreatitis and CK19 is also significant decreased in transgenic 
animals with pancreatitis (Fig. 4.38B). Amylase and elastase levels are normal reduced in 
pancreatitis, while the CK19 mRNA level is increased.  
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Fig. 4.38 Quantitative real time PCR of cDNA from two month old control and transgenic 
littermates with (B) and without (A) pancreatitis (n=4/group). 
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5. DISCUSSION  
 
 
5.1 Overview 
 
The transgenic mouse lines overexpressing betacellulin described in this study provide the 
first opportunity to study in vivo both the membrane-bound and soluble forms of BTC and 
their effects on various target tissue. In the past in vivo experiments to investigate the function 
of BTC, rodents received recombinant mature BTC and therefore only the effect of the 
soluble form of BTC was observed. This approach was often used in diabetes research where 
streptozotocin-induced diabetic rodents were treated with recombinant BTC (Yamamoto et al. 
2000; Li et al. 2003). Another important consideration is that posttranslational modifications 
of recombinant proteins produced in bacteria such as glycosylation probably differ from the 
glycosylation in proteins produced in mouse cells as a precursor form. 
 
As expected, considering the ubiquitously active chicken beta-actin/CMV promoter 
combination employed, increased levels of the precursor form of BTC were detected in many 
tissues from transgenic mice. However, it was not possible to detect the circulating mature 
BTC consistently in serum or plasma samples. This may be related to limited sensitivity of 
Western blot analysis or short half-life of mature BTC. However, we cannot exclude that, to 
some extent, the effects described in this report are caused by the membrane-bound BTC 
precursor or the cell-associated BTC fragment that remains after shedding. Importantly, 
interactions with several different proteins and even modulation of the cellular transcriptional 
program have recently been assigned for the cell-associated HBEGF remnant (Nanba et al. 
2003) and this may be a general mechanism of EGFR ligand activity. 
 
BTC transgenic mice from L2 and L4 exhibited reduced body weight gain from early 
postnatal life in both genders, and adult animals were significantly lighter as compared to 
their littermates. Longitudinal growth of transgenic mice was also affected as demonstrated by 
reduced nose-rump-length (NRL) and reduced relative NRL (Schneider et al. 2005). Stunted 
growth was also reported in transgenic mice ubiquitously overexpressing other ligands of the 
EGF family such as TGFA (Sandgren et al. 1990) or EGF (Chan and Wong 2000; Wong et al. 
2000). Transgenic mice and control littermates were killed at the age of 9 weeks and their 
organs were weighed. In spite of the significantly reduced body weight of BTC transgenic 
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mice, only pancreas and kidneys were reduced in weight as compared to controls. The 
reduction of kidney weight was proportionate to body weight, whereas pancreas weight was 
overproportionately decreased. BTC is known for its mitogenic properties on beta-cells. In the 
adult mouse, the volume fraction of beta-cells in the pancreas is known to account for less 
than 1% (Herbach et al. 2005). Therefore, the weight reduction of the pancreas is due to a 
negative effect of BTC on the exocrine pancreas. The absolute weights of several other organs 
were either unchanged or increased in BTC transgenic mice. For the weights of eyes, lung, 
stomach, intestine and spleen the increase reached statistical significance. The relative 
weights of these organs as well as those of liver, heart and ovaries were also significantly 
increased in BTC overexpressing mice. In contrast, BTC transgenic mice exhibited 
significantly reduced absolute and relative carcass weights. The carcass is composed of 
muscle, bone, fat and connective tissue and comprises a large portion of total body weight 
(Schneider et al. 2005). An overproportionate reduction in carcass weight associated with 
increased weights of several internal organs was also reported for transgenic mice 
ubiquitously overexpressing TGFA (Sandgren et al.  1990).  
 
In this thesis, the functional and histological alterations in the gastrointestinal tract and in the 
exocrine pancreas of mice overexpressing BTC were examined. In addition, we expanded our 
analysis by crossing BTC transgenic mice with animals carrying a mutant Egfr allele (Wa5) 
or with the Apc+/Min mouse model of intestinal cancer. 
 
5.2 Alterations in the stomach of BTC transgenic mice 
 
BTC transgenic mice exhibit a remarkable, age-dependent hyperplasia of the gastric 
epithelium. The lesions were characterized by a tumor-like hyperplasia of foveolar epithelium 
with large cystic formations and a severe depletion of the preexisting body of the mucosa, 
thus resembling some aspects of human gastric tumors found in patients with Ménétrier 
disease. This hyperproliferative disorder of the stomach is also characterized by foveolar 
hyperplasia of superficial gastric glands, glandular cystic dilatation, and decreased acid 
production, and is associated with local overabundance of TGFA and consecutive 
hyperactivation of the EGFR signaling (Coffey et al. 2007). Similar lesions have been 
described in transgenic mice overexpressing TGFA (Dempsey et al. 1992; Takagi et al. 1992; 
Takagi et al. 1997; Bockman et al. 1995; Sharp et al. 1995; Goldenring et al. 1996), but not in 
mouse models overexpressing other EGFR ligands. 
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As a consequence of the massive growth of the tumor-like structures, the stomach weight 
increased to represent about 10% of the total body weight in older animals (~ 12 months), 
which is much more pronounced than the increase in the stomach weight reported for TGFA 
transgenic mice (Sharp et al. 1995). In analogy to the findings reported in TGFA transgenic 
mice, BTC transgenic  animals showed hypoalbuminuria (due to protein loss across the 
mucosa) and an increase in the gastric pH (as a consequence of parietal cell depletion), while 
gastrin levels were not altered. This apparently paradoxical finding, also present in TGFA 
transgenic mice and in Ménétrier patients, may be explained by an EGFR-mediated 
redirection of gastric progenitor cells towards the surface mucous cell lineages at the expense 
of parietal cells (Coffey et al.  2007). 
The mechanisms leading to the development of the lesions we observed have to be discussed 
in the context of gastric development and morphogenesis. Although BTC overexpression 
directed by the actin promoter already commences at midgestation (data not shown), the 
earliest lesions could be observed only at the age of 4 weeks. Before, stomach mucosa 
developed normally. In this context, it is important to note that the organogenesis of the 
mouse stomach initiates at midgestation, while full morphogenesis (development of gastric 
glands and cellular lineage commitment) is only accomplished during the first weeks of 
postnatal life. Thus, excess of BTC during embryonic and postnatal development does not 
affect normal stomach development or initial lineage determination. The earliest 
morphological changes were characterized by a disorganization of the basal glands, with 
initial hyperproliferation. However, in advanced tumors, proliferation was relatively low. In 
none of the mice we investigated did we observe progression of the hyperplastic lesions to 
dysplastic or invasive tumors. Thus, while BTC seems to favor growth of the gastric mucosa, 
it does not initiate or promote malignant alterations. 
Interestingly, the hyperplastic lesions originated exclusively in the lesser curvature of the 
stomach. In this region, endogenous BTC expression is low as compared to the greater 
curvature (where lesions have never been observed). In addition, the normal pattern of cellular 
proliferation (i.e., restricted to the progenitor zone in the isthmus) is maintained in the greater 
curvature. Thus, the lesser curvature, with its comparatively low level of endogenous BTC 
production, appears to be more sensitive to increased levels of this protein. 
Another important aspect of the gastric lesions was the pronounced infiltration with 
mononuclear cells. Gastric inflammation is regularly observed during infection with 
Helicobacter pylori in humans, which can lead to development of stomach cancer. Other 
hyperplastic alterations in the stomach such as Ménétrier disease have been linked to H. pylori 
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infection. The chronic inflammatory process in the stomach is considered to be necessary for 
the development of gastric tumors (Fox et al. 2002). In order to further characterize the 
inflammation in BTC transgenic mice, the mucosal cytokine and cytokine receptor profile was 
evaluated by quantitative real-time PCR. The pattern of cytokine expression reflected an 
unspecific active inflammation. Such inflammatory response can be observed during 
opportunistic, secondary infections. The fact that inflammation only occurred after 
establishment of gastric lesions further supports the concept of a secondary effect, which 
could be due to local chemokine production in response to BTC overexpression and EGFR 
activation. 
On closer examination of the histological appearance of the BTC induced lesions, we 
observed striking differences to the alterations described in the stomach of TGFA transgenic 
mice (resembling Ménétrier disease). Thus, we directly compared the lesions induced by BTC 
in the transgenic stomach to gastric samples obtained from patients with Ménétrier disease 
(Coffey et al. 2007) or pyloric gland adenoma (PGA) (Vieth et al. 2006). Pyloric gland 
adenoma (PGA) is a rare neoplasia of the gastric mucosa, accounting for 2.7 % of all gastric 
polyps (Vieth et al. 2003). Clinically, PGA is more frequent in old-aged females than males. 
PGA is mostly located in the mucosa of the fundus and corpus although very rare in the 
cardia, antrum and intermediate zone of the gastric mucosa (Vieth et al. 2003). Human PGA 
(adenoma with gastric differentiation) derives from a neoplastic proliferation of deep gastric 
glands (pyloric glands) (Vieth et al. 2006) and is characterized by large cystic dilatations, an 
aspect which highly resembled the histology we observed in lesions from BTC transgenic 
mice. Interestingly, we observed upregulation of BTC expression also in PGA samples, while 
it was low in Ménétrier disease. Conversely, TGFA was highest in Ménétrier´s disease and 
also detectable in PGA, but low in lesions from BTC transgenic mice. Thus, the Btc-derived 
alterations exhibit features of both human entities, but seem to represent a unique histological 
entity. 
In conclusion, our study is the first to reveal an association between gastric hyperplastic 
lesions and overabundance of an EGFR ligand but TGFA. Further analysis of differential 
signaling pathways activated by BTC in contrast to TGFA in gastric cells will be necessary to 
better understand the different effects caused by these related growth factors in the stomach. 
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5.3 Alteration of BTC transgenic mice in the intestine 
Differences in intestine size between control FVB and BTC transgenic mice became visible to 
the unaided eye at the age of ~8 weeks and increased to be obvious in older animals. 
Quantitative analysis revealed that the small intestine of transgenic mice was significantly 
reduced in length and an increase in weight was detected both in the small and large intestine. 
Small intestine villi were significantly narrower and longer in BTC transgenic mice as 
compared to control littermates. Analysis of well-oriented histological sections of intestinal 
rolls revealed a diffuse thickening of the mucosa. Evaluation of PAS-stained histological 
sections showed a normal distribution of goblets cells. In fact, no changes in the cell 
distribution along the crypt-villus axis could be detected, indicating that the normal pattern of 
maturation and migration of cells is maintained in the intestine of Btc transgenic mice (data 
not shown). Histological evaluation of the intestinal epithelium of control and transgenic 
animals at different ages (up to 12 months) failed to reveal pathological alterations, such as 
fibrosis, metaplastic or neoplastic lesions. Although it has been shown previously that the 
transgene-derived BTC is expressed in the intestine (Schneider et al. 2005) no information 
was available about its spatial localization. In situ hybridization revealed considerably higher 
amounts of Btc message in the intestinal epithelium and mesenchyme of transgenic mice as 
compared to control animals. Surprisingly, immunohistochemistry revealed that increased 
BTC protein amounts were detected almost exclusively in the mesenchyme, while the 
epithelial cells were mostly negative (Dahlhoff et al. 2008). 
To evaluate intestinal cell proliferation, transgenic and control mice received BrdU two hours 
before necropsy. Immunohistochemical detection of BrdU incorporation revealed a greatly 
expanded zone of proliferating cells in the crypts of transgenic mice and quantitative analysis 
confirmed a significantly higher number of BrdU-positive cells/crypt in the transgenic group. 
This finding is in contrast to the results obtained after the administration of recombinant BTC 
(Howarth et al. 2003). This difference can have multiple causes, including the different 
actions exerted by the full-length, membrane-bound peptide (our studies) or the soluble, 
mature peptide (Howarth et al. 2003); furthermore, our transgenic mice have been exposed to 
higher than normal levels of BTC since the embryonic development, while Howarth and 
colleagues administered the peptide to adult animals and only for a limited number of days. 
Since BTC is able to activate the ERBB4 receptor in addition to the EGFR (Riese et al. 1996), 
a genetic approach was employed to evaluate to which extent the mitogenic effect of BTC is 
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mediated by the EGFR. Specifically, BTC transgenic mice were crossed with a mouse strain 
carrying the antimorphic allele EgfrWa5, whose product acts as a dominant negative EGFR 
(Lee et al. 2004). The thickening of the intestinal mucosa present in BTC transgenic animals 
was completely abrogated in double mutant mice (data not shown). Further, the weight of 
small and large intestine of double mutant mice returned to the levels observed in control or 
Wa5 animals. Since the product of the EgfrWa5 allele selectively inactivates the EGFR but not 
the related ERBB2-4 receptors (Genther Williams et al. 2005), these findings strongly suggest 
that the phenotypical alterations observed in the intestine of BTC transgenic mice are 
completely mediated by the EGFR. 
To test the potential involvement of BTC in tumor formation,  the widely used Apc+/Min mouse 
model of intestinal cancer was employed (Moser et al. 1990). The BTC transgene was 
introduced into mice carrying a wild-type or an Apc+/Min allele and the colony was monitored 
on a daily basis. First signs of illness were apparent in some animals at the age of five months 
and all mice were killed at this age and the total number of polyps and their size were 
counted. BTC overproduction had a profound effect on the number of polyps arising in 
Apc+/Min mice. In contrast, no effect on tumor size was detected (Dahlhoff et al. 2008). Our 
results are in line with the strong reduction in polyp multiplicity, but not in tumor growth due 
to decreased EGFR activity, as described in Apc+/Min mice homozygous for the hypomorphic 
allele Egfrwa2 (Roberts et al. 2002) or carrying the antimorphic allele Egfrwa5 (Lee et al. 2004). 
Roberts et al. (Roberts et al. 2002) proposed the concept that nascent tumors - which are 
highly susceptible to being lost – require a threshold level of EGFR activity to become 
established. Once a certain growth stage is reached, tumor survival can be achieved by the 
already initiated downstream activity or by parallel, EGFR-independent tumorigenic events. 
This model would also predict that increasing EGFR activity would produce an increase in 
polyp number, and our results demonstrate that this is true.  
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5.4 Alteration of the exocrine pancreas in BTC transgenic mice 
 
At necropsy, a reduction in the size of the pancreas in transgenic mice of both genders was 
easily observable and this impression was confirmed by quantitative analyses. Since the BTC-
transgenic animals show a reduction in total body weight as compared to their control 
littermates, the relative pancreas weight was calculated. Interestingly, the relative pancreas 
weight was also reduced (Schneider et al. 2005). This is a remarkable finding, since in the 
literature betacellulin is known as a mitogen (Shing et al. 1993). These results, however, are 
based on only one time point. To clarify if the pancreas weight loss increases with the age, the 
natural logarithm of the body weight was plotted against the natural logarithm of the pancreas 
weight to determine the growth allometry (Shea et al. 1987). The result shows two parallel 
lines in which the transgene line goes below the control line. It can be therefore postulated 
that betacellulin negatively affects pancreas growth predominantly during embryonic 
development and early postnatal life; the organ weight deficit observed in adult animals is 
therefore the result of an effect of BTC in the embryonic development.  
In order to investigate whether this effect was a result of restricted expression of the transgene 
or its receptors in a specific pancreatic compartment, we employed immunohistochemistry. 
While betacellulin expression is limited to the islets in non-transgenic mice, expression of the 
growth factor can be detected through the whole organ in transgenic animals (beginning at 
e15.5). Thus, the negative effect observed in the exocrine pancreas may be a result of the 
“unnatural” expression of this peptide in this tissue. Since the data collected from the 
literature did not provide clear-cut information about the expression sites of ERBB1 and 
ERBB4 (the primary receptors for betacellulin), and mouse strain can be a complicating 
factor, we determined the expression site of these receptors by immunohistochemistry. While 
ERBB1 is expressed predominantly in the islets, ERBB4 expression is nearly absent in the 
endocrine tissue but is high in the exocrine part (ERBB4 expression could be detected at some 
putative α-cell as previously reported (Kritzik et al. 2000; Huotari et al. 2002). This opposite 
expression pattern of the two receptors in endocrine and exocrine pancreatic tissue provides a 
complementary explanation for the contrasting effects exerted by betacellulin in this organ.  
To evaluate to which extent this pancreatic phenotype is EGFR-dependent; we mated BTC-
transgenic mice to animals carrying the antimorphic allele EgfrWa5, whose product is a kinase-
dead receptor. Double mutant mice in the progeny showed a rescue of almost all transgene-
induced alterations with the notable exception of the reduction in pancreas weight. Therefore, 
it can be concluded that this alteration is, at least to a great extent, EGFR-independent. The 
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strong ERBB4 immunoreactivity in the exocrine tissue suggests a role for this receptor in 
mediating the effects of BTC. 
 
To characterize the mechanisms underlying this unknown hitherto effect of BTC, cell 
proliferation and apoptosis in the exocrine compartments of the pancreas were evaluated. 
Proliferation and apoptosis were significantly increased in BTC transgenic versus control 
mice, both parameters by a factor of approximately 2.8. However, the reduction of the 
exocrine pancreas is not progressive (as discussed above), and so the net result of this 
increased apoptosis and proliferation rate of the exocrine pancreas in BTC transgenic mice 
may be related to a higher cell turnover. 
 
Overexpression of several EGFR ligands in the pancreas of transgenic mice has been 
accomplished by different laboratories and results in a variety of phenotypes depending on 
which growth factor is overexpressed and in which cell population overexpression takes 
place. Overexpression of TGFA by acinar cells resulted in massive increase in organ weight, 
fibrosis, and adenocarcinomas (Sandgren et al. 1990; Jhappan et al. 1990; Bockman and 
Merlino 1992; Wagner et al. 1998; Wagner et al. 2001). In contrast, overexpression of 
amphiregulin by acinar cells merely increased cell proliferation and caused expansion of duct 
cells (Wagner et al. 2002). Interestingly, β-cell-targeted overexpression of EGFR ligands 
appears to affect both the endocrine and the exocrine fractions. Excess of EGF in β-cells 
caused an increase in islet size, islet disaggregation and peripheral fibrosis but also lead to a 
detection of insulin-positive cells and an increase in cell proliferation in the non-islet 
compartment (Krakowski et al. 1999). Overexpression of HBEGF in β-cells resulted in an 
altered cell distribution within the islet, poor segregation from the exocrine part and invasion 
of stroma cells. In addition, the non-islet compartment showed fibrosis and ductal metaplasia 
in older animals (Means et al. 2003). Thus, overexpression of betacellulin resulted in a unique 
set of pancreatic alterations. 
 
Acute pancreatitis is a common gastrointestinal disorder of the exocrine pancreas. It has a 
wide range of clinical symptoms that vary from a mild, self-limiting upper abdominal pain to 
multiorgan failure and sepsis with high mortality (Wagner et al. 2000). It has been previously 
shown that EGF has a protective effect against acute pancreatitis. Rats with caerulein-induced 
pancreatitis were treated with EGF and showed decreased amylase and lipase levels 
(Warzecha et al. 1999). Another study examined the influence of endogenous and exogenous 
 99
                                                                                                                                       Discussion 
EGF on pancreatitis repair after acute disease induction. For this purpose, caerulein induced 
pancreatitis was induced in rats with intact or removed salivary glands and EGF was 
administered. It was shown that EGF reduced the pancreatic damage and accelerated the 
tissue repair after caerulein-induced pancreatitis (Dembinski et al. 2000).  
 
Considering that EGF, in contrast to BTC, is not able to bind ERBB4 and that ERBB4 is 
strongly expressed in the exocrine pancreas, we decided to investigate whether BTC plays a 
similar or even quantitatively superior role in protecting from pancreatitis. Acute pancreatitis 
induced by a supraphysiological dose of caerulein, a cholecystokinin-8 (CCK-8) analog, is 
one of the best studied animal models for this disease (Lampel and Kern 1977). Caerulein 
normally causes a non-lethal, mild, necrotizing pancreatitis in mice which is self-limiting. The 
disease is mediated through premature intracellular activation of a cascade of digestive 
zymogens which finally results in acinar cell necrosis a mild pancreatic edema, and is 
followed by an inflammatory response including leukocyte infiltration. Furthermore, amylase 
leakage from injured acinar cell causes hyperamylasemia (Grady et al. 1998).  
Serum amylase and lipase, the first markers for pancreatitis were significantly reduced in 
BTC-transgenic mice, a first indication that the transgenic animals were less sensitive to the 
induced pancreatitis. To clarify if the BTC-transgenic mice have generally decreased serum 
amylase and lipase levels, a Western blot of amylase was performed and serum amylase and 
lipase levels were measured transgenic animal and control animals without caerulein 
treatment. No alteration was detected in these experiments so it can be postulated that the 
amylase production in the pancreas of transgenic mice was normal. The results of the 
performed histological score confirmed the serum analysis: the transgenic animals showed 
reduced oedema, less inflammatory cells in the pancreas and almost no acinar necrosis. These 
impressive results may be a consequence of the high apoptosis index in the BTC-transgenic 
mice and this may represent the reason for the protection against acute pancreatitis. Thus, 
shifting death responses from necrosis to apoptosis may have a therapeutic value. 
Interestingly, caerulein-induced pancreatitis in rats shows a mild disease characterized by 
relatively high extent of apoptosis and low necrosis, in contrast to mice which have significant 
necrosis and little apoptosis (Kaiser et al. 1995). It was reported that the receptor inactivating 
protein (RIP), a key mediator of “programmed” necrosis, was cleaved (inactivated) in the rat 
but not in the mouse model (Mareninova et al. 2006). We failed to detect changes in the levels 
of cleaved RIP between BTC-transgenic animals and control mice. To study the reason for the 
high apoptosis index in Btc-tg mice Western blots were performed to evaluate the activity of 
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relevant signalling molecules. The proteins Bcl-2 and Bcl-xL function as inhibitors of 
programmed cell death, whereas other proteins from the Bcl-2 family like Bax promote 
apoptosis when it homodimerize or heterodimerize with Bcl-2. No alteration could be 
detected by Western blot analysis in these proteins in transgenic mice compared with control 
littermates. Activation of MAPK modules including ERK1/2, p38 and SAPK are induced 
rapidly and transiently during acute experimental pancreatitis in rodents (Schafer and 
Williams 2000). These modules are generally believed to be part of the cellular stress 
response machinery in the onset of inflammation in the pancreas. ERK 1 and 2 dimers are 
phosphorylated and influence a host of responses that includes proliferation, differentiation, 
transcription regulation and development. Both molecules showed no altered phosphorylation 
or expression levels in BTC transgenic mice as compared with control littermates. During 
apoptosis PARP can be cleaved from a 113 kDa intact form into 89 kDa and 24 kDa 
fragments (Gallagher et al. 2005). However, PARP activity was also unaltered and therefore 
not responsible for the higher apoptosis index in transgenic mice with pancreatitis. SAPKs, 
also called c-Jun amino-terminal kinases (JNKs), are related to the MAP kinases and are the 
dominant JNKs activated in response to stressful stimuli including environmental stresses like 
UV and gamma radiation, inflammatory cytokines, heat shock, inhibitors of protein synthesis 
and in some instances growth factors (Grady et al. 1996). When active as a dimmer, JNK can 
translocate to the nucleus where it regulates transcription through its effects on c-Jun, ATF-2, 
Elk1 or other transcription factors, which can induce programmed cell death. We were able to 
detect a significant increase in JNK2/3 phosphorylation in the pancreatic tissue of caerulein-
induced Btc-tg mice. Thus, increased JNK2/3 phosphorylation could be the reason for the 
increased apoptosis rate in BTC transgenic mice and for their reduced sensitivity to caerulein-
induced pancreatitis.   
 
Under some circumstances, endoplasmic reticulum stress (ER-stress) can induce highly 
increased programmed cell death (Kubisch et al. 2006). In some transgenic animal models or 
mutants, the expression of the transgene or the mutant gene product is so strong that the cells 
cannot cope with the abnormally high protein amounts and undergo ER-stress, which results 
in apoptosis (Araki et al. 2003). To exclude ER-stress as the mechanism behind the reduced 
necrosis observed after induction of pancreatitis in BTC-transgenic mice, the eIF2 activity 
was assessed. The α-subunit of eIF2 could be phosphorylated by PERK (pancreatic 
endoplasmic reticulum kinase) what is highly the matter when stress is provoked by depletion 
of endoplasmic reticulum calcium levels. The initiation factor shows no altered activity in the 
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tissue from the BTC-transgenic group with pancreatitis as compared to their littermates and 
ER-stress is therefore highly improbable as the mechanism responsible for the increased 
apoptosis. 
 
5.5 Final considerations 
 
The fact that mice lacking AREG, BTC, EGF, EREG, TGFA, and even triple null mice 
deficient for AREG, EGF and TGFA are viable, clearly indicates a high degree of functional 
compensation within the family of EGFR ligands. Although careful examination of these 
mouse mutants did reveal specific defects in tissue homeostasis under challenge situations, the 
opposite approach, this is, the overexpression of single ligands, appears to be a much more 
adequate strategy for unravelling their functions in physiology and pathology. The remarkable 
phenotypical alterations in transgenic mouse lines overexpressing BTC described in this study 
support this concept. 
  
Furthermore, choosing a promoter providing ubiquitous expression of the transgene revealed 
to be a rewarding strategy for the initial characterization of BTC effects in diverse organs. In 
some cases, as in the gastrointestinal alterations reported here, a detailed characterization is 
possible employing the already available lines. In other situations, when an interesting 
alteration is observed but there are concerns about its correct interpretation due to the 
ubiquitous growth factor overexpression (e.g. endocrinological studies), new transgenic lines 
with tissue specific expression of the transgene can be generate to specifically address these 
questions.  
 
Thus, transgenic mouse lines remain undisputedly a powerful and necessary tool for studying 
the function and the potential actions of poorly characterized proteins in different organs. 
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6. Summary  
Actions of betacellulin in the gastrointestinal tract: studies in transgenic mouse lines 
 
This work employed a transgenic mouse model to investigate the functions and effects elicited 
by the peptide growth factor betacellulin (BTC), an EGFR ligand, on the physiology and 
pathology of the gastrointestinal tract.  
 
BTC, a 32-kDa glycosylated protein, was initially purified from a mouse pancreatic β-cell 
carcinoma cell line. In addition to the EGFR, BTC is also able to directly bind and activate the 
related ERBB4 receptor. BTC is expressed in a wide variety of tissues, particularly in the 
pancreatic β-cells, stomach, small intestine, lung, kidney and uterus.  
Three different transgenic mouse lines (L2, L4, and L5) overexpressing BTC under the 
control of a ubiquitous promoter were established by pronuclear DNA microinjection. 
Southern blot analysis revealed different integration sites for each line.  
RT-PCR, Northern and Western blot analysis revealed strong expression of the transgene in 
the lung, heart, brain and pancreas, with detectable levels in other tissues like stomach, 
intestine, muscle, bones, liver, thymus, spleen, kidneys, adrenal glands, ovaries, brain and 
eyes of transgenic mice. BTC-transgenic mice showed stunted growth and significantly 
reduced relative pancreas and carcass weights. In contrast, the absolute and relative weights of 
eyes, lung, stomach, intestine and spleen were significantly increased.  
 
BTC-transgenic mice exhibit a remarkable, age-dependent hyperplasia of the gastric 
epithelium. The lesions were characterized by a tumor-like hyperplasia of foveolar epithelium 
with large cystic formations and a severe depletion of the preexisting body of the mucosa, 
thus resembling some aspects of human gastric tumors found in patients with Ménétrier 
disease where TGFA, another ligand of the EGFR, plays an important role. BTC-transgenic 
animals showed hypoalbuminemia (due to protein loss across the mucosa) and an increase in 
the gastric pH (as a consequence of parietal cell depletion), while gastrin levels were not 
altered. The hyperplastic lesions originated exclusively in the lesser curvature of the stomach 
and were histologically detectable for the first time at the age of 4 weeks. Another important 
aspect of the gastric lesions was the pronounced infiltration with mononuclear cells. Gastric 
inflammation is regularly observed during infection with Helicobacter pylori in humans, 
which can lead to development of stomach cancer or Ménétrier disease. In conclusion, our 
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study is the first to reveal an association between gastric hyperplastic lesions and 
overabundance of an EGFR ligand but TGFA.  
 
BTC-transgenic mice showed a significant reduction in the length of small and large intestine 
while the weight of theses tissues was significant increased. The villi were narrower and 
longer as compared with control littermates. No pathological alterations such as fibrosis, 
metaplastic or neoplastic lesions could be found in the intestinal mucosa of transgenic 
animals, but the cell proliferation index was increased. It was further demonstrated that the 
BTC effects in the intestine are EGFR-dependent and that BTC overproduction increases the 
multiplicity of intestinal adenomas in Apc+/Min mice.  
 
A distinct expression pattern of ERBB1 and ERBB4 could be responsible for the significantly 
reduced pancreas weight in BTC-transgenic mice: ERBB1 is expressed predominantly in the 
islets, while ERBB4 expression is nearly absent in the endocrine tissue but is high in the 
exocrine part. It can be postulated that the reduced exocrine pancreas is mediated by the 
ERBB4 receptor and not by the EGFR. This concept is supported by the maintenance of the 
pancreas weight reduction in BTC-transgenic mice in an EGFR-deficient background.  
 
To evaluate the functional consequence of BTC excess in the pancreatic tissue, we submitted 
transgenic mice to caerulein-induced acute pancreatitis. The serum markers indicative of 
pancreatitis were significant lower in the transgenic mice as compared to their control 
littermates, an indication for a weaker pancreatitis in this group. Further, BTC-transgenic 
animals developed less tissue inflammation, pancreatic edema and acinar necrosis. 
Interestingly, BTC-transgenic mice showed significantly higher levels of apoptosis during 
pancreatitis as compared to their littermates. Further studies will be necessary to investigate 
whether a shift in death response from necrosis to apoptosis is the mechanism resulting in a 
protection against caerulein-induced pancreatitis. If confirmed, this finding may have 
important therapeutic implications. 
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7. Zusammenfassung 
 
Analyse des gastrointestinalen Traktes von Betacellulin transgenen Mäusen 
 
In dieser Arbeit wurde ein transgenes Mausmodell, welches den Wachstumsfaktor 
Betacellulin, einen Liganden des EGFR überexprimiert, auf seine physiologischen und 
pathologischen Auswirkungen auf den Gastrointestinaltrakt hin untersucht. 
 
Betacellulin ist ein 32-kDa großes glykosyliertes Protein, das erstmals aus einer murinen β-
Zellkarzinom-Zelllinie isoliert wurde. Zusätzlich zum EGFR (ERBB1) bindet BTC den 
ERBB4 Rezeptor, der wie die Rezeptoren ERBB2 und ERBB3 auch zur EGFR Familie 
gehört. BTC wird in vielen verschiedenen Geweben natürlich exprimiert, besonders in den 
pankreatischen β-Zellen, im Magen, Dünndarm, Lunge, Nieren und Uterus. 
Mittels DNA-Mikroinjektion in die Vorkerne von Zygoten wurden drei verschiedene 
transgene Mauslinien (L2, L4 und L5) erstellt, welche BTC unter der Kontrolle des 
ubiquitären chicken-β-actin Promotors überexprimieren. In der Southern-Blot-Analyse 
wurden unterschiedliche Integrationsorte für die drei Linien nachgewiesen. 
RT-PCR, Northern- und Western-Blot-Analysen haben eine starke Expression des Transgens 
in Lunge, Herz, Gehirn und Pankreas nachgewiesen, aber auch in Organen wie Magen, Darm, 
Muskel, Knochen, Leber, Thymus, Milz, Niere, Nebenniere, Eierstöcke und Augen konnte 
eine Überexpression von BTC in den transgenen Mäusen dokumentiert werden. BTC 
transgene Tiere zeigen außerdem ein vermindertes Wachstum und ein signifikant reduziertes 
relatives Pankreas- und Karkassengewicht. Auf der anderen Seite sind die absoluten und 
relativen Gewichte der Augen, der Lunge, des Magens, des Darms und der Milz statistisch 
signifikant erhöht.  
 
BTC transgene Mäuse zeigen eine ausgeprägte, altersabhängige Hyperplasie der 
Magenschleimhaut, die bei sehr alten Tieren als riesiger Polyp das Magenlumen ausfüllen 
kann. Die Veränderungen sind durch Hyperplasie des foveolaren Magenepithels mit großen 
zystischen Formationen, die die normale Magenmukosa auflöst, gekennzeichnet. Sie haben 
große Ähnlichkeit mit Veränderungen, die bei Patienten mit Morbus Ménétrier auftreten. Bei 
dieser Erkrankung spielt TGFA, ein anderer Ligand des EGFR, eine wichtige Rolle. BTC 
transgene Mäuse sind durch einen stetigen Proteinverlust über die Magenschleimhaut 
hypoalbuminämisch und weisen als Konsequenz der Rückbildung der Parietalzellen einen 
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erhöhten pH-Wert im Magen auf, während die Gastrinspiegel unverändert sind. Der 
hyperplastische Polyp entsteht ausnahmslos an der kleinen Kurvatur des Magens und ist im 
Alter von vier Wochen erstmals histologisch nachweisbar. Ein weiterer interessanter Punkt, 
der bei den Magenveränderungen auftritt, ist eine Entzündung, die von mononukleären Zellen 
beherrscht wird. Magenentzündungen werden regelmäßig bei Menschen mit Helicobacter 
pylori Infektionen beobachtet, sie stehen im Verdacht Morbus Ménétrier auslösen zu können. 
Zusammenfassend ist dies die erste Studie, die auf einen Zusammenhang zwischen Morbus 
Ménétrier und einem verstärkten Vorkommen eines anderen Liganden des EGFR außer 
TGFA hinweist.  
 
BTC transgene Mäuse zeigen eine signifikante Reduktion der Länge des Dünn- und 
Dickdarms, während das Gewicht beider Darmabschnitte signifikant erhöht ist. Die 
Darmzotten sind zahlreicher und länger als bei den Kontrolltieren. Es wurden keine 
pathologischen Veränderungen wie Fibrose, Meta- oder Neoplasien gefunden, aber es konnte 
bei den transgenen Tieren eine erhöhte Zellproliferation in der Dünndarmschleimhaut 
nachgewiesen werden. Weiter konnte gezeigt werden, dass die Effekte im Dünndarm durch 
EGFR vermittelt sind und eine Überexpression von BTC zu einem Anstieg von Adenomen in 
Apc+/Min-Mäusen führt. 
 
Ein charakteristisches Verteilungsmuster vom ERBB1- und ERBB4-Rezeptoren könnte die 
Erklärung für das signifikant reduzierte Pankreasgewicht in BTC transgenen Mäusen sein: 
ERBB1 wird dominierend in den Langerhans`schen Inseln des Pankreas exprimiert, während 
ERBB4 nahezu gar nicht im endokrinen Gewebe, aber dafür sehr stark im exokrinen Teil des 
Pankreas exprimiert wird. Diese Ergebnisse lassen vermuten, dass die Volumenreduktion im 
exokrinen Pankreas durch den ERBB4 Rezeptor vermittelt ist und nicht vom EGFR ausgeht. 
BTC transgene Mäuse wurden in einen genetischen Hintergrund mit funktionslosem EGFR 
eingekreuzt, um diese Annahme zu bestätigen. 
 
Um die Funktion von BTC im exokrinen Pankreas näher zu untersuchen, wurde in den 
Mäusen eine akute Pankreatitis, durch Caerulein hervorgerufen, induziert. Die Serumspiegel 
der Pankreatitismarker Amylase und Lipase waren bei den transgenen Tieren, verglichen mit 
den Kontrolltieren, signifikant reduziert, was für einen wesentlich schwächeren 
Pankreatitisverlauf in der transgenen Gruppe spricht. Außerdem entwickelten die transgenen 
Tiere so gut wie keine Nekrosen, was aber zum Erscheinungsbild der Pankreatits bei Mäusen 
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gehört. Auch Ödeme und das Auftreten von Entzündungszellen waren nicht so ausgeprägt wie 
bei den Kontrolltieren. Interessant ist, dass die transgenen Mäuse einen signifikant erhöhten 
Apoptoseindex aufwiesen. Vielleicht ist diese Verschiebung von der Nekrose zur Apoptose 
die Erklärung für den protektiven Effekt, den das Transgen auf das Pankreas nach Caerulein 
Behandlung zeigt. Eventuell könnte BTC einen therapeutischen Nutzen bei Pankreatitis 
haben. 
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